User login
Comparing Collaborative and Toolkit QI
Continuous quality improvement (CQI) methodologies provide a framework for initiating and sustaining improvements in complex systems.1 By definition, CQI engages frontline staff in iterative problem solving using plandostudyact cycles of learning, with decision‐making based on real‐time process measurements.2 The Institute for Healthcare Improvement (IHI) has sponsored Breakthrough Series Collaboratives since 1996 to accelerate the uptake and impact of quality improvement (QI).3, 4 These collaboratives are typically guided by evidence‐based clinical practice guidelines, incorporate change methodologies, and rely on clinical and process improvement subject matter experts. Through the collaborative network, teams share knowledge and ideas about effective and ineffective interventions as well as strategies for overcoming barriers. The collaborative curriculum includes CQI methodology, multidisciplinary teamwork, leadership support, and tools for measurement. Participants are typically required to invest resources and send teams to face‐to‐face goal‐oriented meetings. It is costly for a large healthcare organization to incorporate travel to a learning session conference into its collaborative model. Thus, we attempted virtual learning sessions that make use of webcasts, a Web site, and teleconference calls for tools and networking.5
A recent derivative of collaboratives has been deployment of toolkits for QI. Intuition suggests that such toolkits may help to enable change, and thus some agencies advocate the simpler approach of disseminating toolkits as a change strategy.6 Toolkit dissemination is a passive approach in contrast to collaborative participation, and its effectiveness has not been critically examined in evidence‐based literature.
We sought to compare the virtual collaborative model with the toolkit model for improving care. Recommendations and guidelines for central lineassociated bloodstream infection (CLABSI) and ventilator‐associated pneumonia (VAP) prevention have not been implemented reliably, resulting in unnecessary intensive care unit (ICU) morbidity and mortality and fostering a national call for improvement.7 Our aim was to compare the effectiveness of the virtual collaborative and toolkit approaches on preventing CLABSI and VAP in the ICU.
Methods
This cluster randomized trial included medical centers within the Hospital Corporation of America (HCA), a network of hospitals located primarily in the southern United States. To minimize contamination bias between study groups within the same facility, the unit of randomization was the hospital and implementation was at the level of the ICU. The project received approval from the Vanderbilt University Institutional Review Board.
Leaders of all medical centers with at least 1 adult or pediatric ICU received an invitation from HCA leadership to participate in a QI initiative. Facility clinicians and managers completed baseline surveys (shown in the Supporting Information) on hospital characteristics, types of ICUs, patient safety climate, and QI resources between July and November 2005. Hospital‐level data were extracted from the enterprise‐wide data warehouse. Hospitals willing to participate were matched on geographic location and ICU volume and then randomized into either the Virtual Collaborative (n = 31) or Toolkit (n = 30) groups in December 20058; 1 of the hospitals was sold, yielding 29 hospitals in the Toolkit (n = 29) group. The study lasted 18 months from January 2006 through September 2007, with health careassociated infection data collected through December 2007, and follow‐up data collection through April 2008.
The QI initiative included educational opportunities, evidence‐based clinical prevention interventions, and processes and tools to implement and measure the impact of these interventions. Participants in both groups were offered interactive Web seminars during the study period; 5 of these seminars were on clinical subject matter, and 5 seminars were on patient safety, charting use of statistical process control and QI methods. The interventions were evidence‐based care bundles.9 The key interventions for preventing CLABSI were routine hand hygiene, use of chlorhexidine skin antisepsis, maximal barrier precautions during catheter insertion, catheter site and care, and avoidance of routine replacement of catheters. The key interventions to prevent VAP were routine elevation of head of the bed, regular oral care, daily sedation vacations, daily assessment of readiness to extubate, secretion cleaning, peptic ulcer disease prophylaxis, and deep vein thrombosis prophylaxis.
Toolkit Group
Hospitals randomized to this arm received a toolkit during study month 1 containing a set of evidence‐based guidelines and fact sheets for preventing CLABSI and VAP, a review of QI and teamwork methods, standardized data collection tools, and standardized charting tools. The nurse and quality managers for the Toolkit ICUs were provided ad libitum access to the HCA intranet toolkit Web site containing all of the educational seminars, clinical tools, and QI tools. Otherwise, ICUs in this group were on their own to initiate and implement a local hospital QI initiative to prevent CLABSI and VAP.
Virtual Collaborative Group
In addition to the materials and Web site support described above, facility leaders and managers in this Virtual Collaborative group agreed to participate in a virtual collaborative to develop processes to more reliably implement evidence‐based interventions to prevent CLABSI and VAP. The collaboration differed from the Breakthrough Series model3, 4 in that teams did not come together for face‐to‐face educational and planning sessions but instead attended Web seminars and teleconferences for reporting back to the larger group.5 Teams were supported through monthly educational and troubleshooting conference calls, individual coaching coordinated by the HCA corporate office of quality, safety, and performance improvement, and an e‐mail listserv designed to stimulate interaction among teams.
Clinical Outcome Measures
Although most participating hospitals defined CLABSI and VAP using the Centers for Disease Control and Prevention definitions, data collection and surveillance methods varied across hospitals.10 Education was provided to standardize outcome measurement. A data registry Web application was created as a new tool for infection control data entry, and healthcare‐associated infection data reporting by the infection control personnel was mandated starting the first quarter of 2006. To verify electronic data and correct missing information, the infection control personnel were requested to complete a retrospective data collection sheet providing quarterly reports from January 2005 through December 2007 on ICU infection events as well as total catheter days and ventilator days to allow calculation of event rates. Outcome measures of CLABSI and VAP were at the level of the hospital.
Follow‐Up
The HCA e‐mail distribution and collection routine was employed for the follow‐up survey of ICU nurse and quality managers for all participating medical centers from January 2008 through April 2008. A single survey (shown in the Supporting Information) was requested from each participating ICU. The ICU‐level surveys included questions about the implementation of the CLABSI and VAP process interventions, access of tools, participation in Web seminars, and use of QI strategies.11, 12 The postintervention survey also assessed the character and amount of implementation and teamwork activity expended.
Median CLABSI and VAP rates for a 3‐month baseline and quarterly postintervention periods were compared between the 2 study groups. The CLABSI and VAP infection rates were also analyzed using hierarchical negative binomial regression models to model infection rate changes over time (time in months and group by time interaction effects) and account for clustering of ICUs within hospitals and adjusting for baseline covariates. Baseline and process variables at the hospital and ICU level were compared using chi‐square tests and t tests according to the type of measurement. Time‐to‐event analyses were conducted to compare the groups on time to initiation of a care process. All analyses were conducted using the (R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria, 2010).
The power of the study was calculated a priori with a 1‐tailed alpha of 0.05 and group size of 30. We hypothesized a 50% decrease in hospital‐associated infection rates for the Collaborative group vs. a 10% to 15% decrease for the Toolkit group. The calculations yielded power ranging from a low of 82% to a high of 91% for testing group differences.13
Results
Participating facilities included rural (11%), inner city (28%), and suburban (61%) medical centers. The 60 participating sites did not differ in administrative variables from the 113 nonparticipating HCA sites (results not shown). The median hospital size was 177 beds and the median ICU size was 16 beds. The hospitals did not differ between study groups (Table 1). At baseline, 45% of the facilities reported having a CLABSI program and 62% a VAP program.
Hospital Factors at Baseline | Virtual Collaborative | Toolkit | P Value |
---|---|---|---|
| |||
Number of hospitals | 31 | 29* | |
ICU annual patient volume, median (IQR) | 568 (294, 904) | 578 (244, 1077) | 0.93 |
ICU patient length of stay days, median (IQR) | 3882 (1758, 5718) | 4228 (1645, 6725) | 0.95 |
ICU mortality rate, percent (SD) | 5.7% (3.1%) | 7.1% (3.6%) | 0.13 |
Medicare/Medicaid, percent (SD) | 68.6% (9.5%) | 68.5% (10.1%) | 0.95 |
Percent admitted to ICU from the Emergency Department (SD) | 71% (15%) | 67% (20%) | 0.27 |
Percent female (SD) | 49.7% (5.7%) | 50.3% (7.7%) | 0.79 |
Medicare case‐mix weight, mean (SD) | 1221 (1007) | 1295 (1110) | 0.82 |
Percent hospitalist ICU management | 47% | 40% | 0.61 |
The baseline and quarterly median and pooled infection rates for the Toolkit and Collaboration groups are shown in Table 2 for CLABSI and in Table 3 for VAP. There were no significant differences in the baseline rates for either CLABSI (P = 0.24) or VAP (P = 0.72) between the Collaborative and Toolkit groups. There was no significant change for either CLABSI or VAP outcomes at either 12 or 18 months of follow‐up. The median bloodstream infection rate for all participating hospitals was 2.27 at baseline, 1.18 at 12 months (P = 0.13), and 2.23 per 1000 catheter days 18 months later (P = 0.95). The median VAP rate for participating hospitals was 2.90 at baseline, 2.67 at 12 months (P = 0.44), and 2.52 per 1000 ventilator days 18 months later (P = 0.84). The hierarchical regression analysis found that neither the Collaborative nor Toolkit groups improved CLABSI (P = 0.75 and P = 0.83, respectively) or VAP (P = 0.61 and P = 0.37, respectively) rates over time, and there was no differential performance between the 2 groups for either outcome (bloodstream infection, P = 0.71; VAP, P = 0.80).
Overall | Virtual Collaborative | Toolkit | ||||
---|---|---|---|---|---|---|
N = 59 Hospitals | N = 30 Hospitals | N = 29 Hospitals | ||||
Study Period | Hospital Median (IQR) | Rate Pooled Across Hospitals | Hospital Median (IQR) | Rate Pooled Across Hospitals | Hospital Median (IQR) | Rate Pooled Across Hospitals |
| ||||||
Baseline | 2.27 (0.00‐3.98) | 2.42 | 1.84 (0.00‐3.83) | 1.67 | 2.42 (0.65‐6.80) | 3.05 |
3 Month | 2.27 (1.30‐4.69) | 2.61 | 2.24 (0.54‐4.69) | 2.34 | 2.47 (1.48‐5.35) | 2.85 |
6 Month | 2.37 (0.00‐4.29) | 2.73 | 2.28 (0.00‐3.73) | 2.35 | 2.54 (0.00‐4.98) | 3.09 |
9 Month | 1.66 (0.00‐3.84) | 2.45 | 1.76 (0.00‐3.74) | 2.28 | 1.23 (0.00‐3.93) | 2.59 |
12 Month | 1.18 (0.00‐3.10) | 2.17 | 1.18 (0.00‐2.71) | 1.72 | 1.17 (0.00‐3.61) | 2.58 |
15 Month | 1.93 (0.00‐4.25) | 2.29 | 2.04 (0.00‐4.91) | 2.53 | 1.77 (0.00‐3.30) | 2.08 |
18 Month | 2.23 (0.00‐4.97) | 2.73 | 2.76 (0.00‐4.67) | 2.75 | 1.16 (0.00‐5.46) | 2.72 |
Study Period | Overall | Virtual Collaborative | Toolkit | |||
---|---|---|---|---|---|---|
N = 59 Hospitals | N = 30 Hospitals | N = 29 Hospitals | ||||
Hospital Median (IQR) | Rate Pooled Across Hospitals | Hospital Median (IQR) | Rate Pooled Across Hospitals | Hospital Median (IQR) | Rate Pooled Across Hospitals | |
| ||||||
Baseline | 2.90 (0.00‐6.14) | 3.97 | 2.14 (0.00‐6.09) | 3.43 | 3.49 (0.00‐7.04) | 4.36 |
3 Month | 3.12 (0.00‐8.40) | 4.46 | 3.01 (0.00‐9.11) | 4.22 | 3.32 (0.00‐8.25) | 4.62 |
6 Month | 3.40 (0.00‐7.53) | 4.97 | 2.72 (0.00‐7.09) | 4.81 | 4.61 (0.00‐9.37) | 5.10 |
9 Month | 1.49 (0.00‐4.87) | 2.99 | 0 (0.00‐3.94) | 2.51 | 2.27 (0.00‐6.27) | 3.36 |
12 Month | 2.67 (0.00‐4.60) | 4.39 | 2.67 (0.00‐4.47) | 3.82 | 2.66 (0.00‐4.82) | 4.95 |
15 Month | 3.06 (0.00‐5.10) | 4.03 | 2.40 (0.00‐3.94) | 3.57 | 3.65 (1.15‐6.57) | 4.45 |
18 Month | 2.52 (0.00‐7.45) | 4.61 | 2.93 (0.00‐7.63) | 5.02 | 2.06 (0.00‐6.59) | 4.31 |
The poststudy survey was completed by 27 of 31 (87%) of Collaborative group hospitals and 19 of the 29 (66%) Toolkit hospitals. Both groups reported QI improvement efforts to prevent CLABSI (Collaborative 97% vs. Toolkit 88%, P = 0.29) and VAP (Collaborative 97% vs. Toolkit 96%, P = 0.99). Eighty‐three percent of the Collaborative group implemented all components of the bloodstream infection prevention interventions compared with 64% for the Toolkit group (P = 0.13; Figure 1). The Collaborative group implemented daily catheter review more often than the Toolkit group (P = 0.04) and began the process implementation sooner following study implementation (P = 0.006 vs. Toolkit; see Supporting Information Figure). Eighty‐six percent of the Collaborative group implemented the complete VAP prevention interventions vs. 64% of the Toolkit group (P = 0.06; Figure 1) and the Collaborative group conducted the sedation vacation intervention more often (P = 0.03).

The Collaborative group participated in 57% of the seminars, whereas the Toolkit group participated in 39% (P = 0.014). Members of both groups attended more than half the clinical topics (Collaborative 64% vs. Toolkit 56%, P = 0.37). The Collaborative group had greater participation in the data and method topics (Collaborative 50% vs. Toolkit 22%, P < 0.001). The proportion of hospitals finding the seminars useful to their QI efforts was 49% for the Collaborative and 30% for the Toolkit group (P = 0.017). When restricted to hospitals that participated in the seminars, the usefulness rating was higher for both clinical (91% for the Collaborative and 86% for Toolkit) and Data/Methods (79% for Collaborative and 55% for Toolkit) topics.
A set of 14 tools were produced during the study period (Table 4); 9 clinically related tools (eg, checklists, algorithms, protocols, and flowsheets) and 5 data monitoring and quality improvement tools (eg, easy‐to‐use statistical process control spreadsheet templates, quality improvement tools, and computer tools). The Collaborative group downloaded a median of 10 tools and the Toolkit group a median of 7 (P = 0.051). The groups did not differ in their access to the clinical tools (P = 0.23) but the Collaborative group accessed a greater proportion of the data/methods tools (P = 0.004).
Tool Access and Strategies | Collaborative Hospitalsa | Tool Kit Hospitalsa | P‐value |
---|---|---|---|
N = 36 ICUs | N = 25 ICUs | ||
| |||
Clinical Tool Use | 61% | 49% | 0.23 |
BSI Surveillance Guide | 22/36 (61%) | 13/25 (52%) | 0.60 |
BSI Checklist | 31/36 (86%) | 16/25 (64%) | 0.06 |
VAP Diagnosis Algorithm | 24/36 (67%) | 15/25 (60%) | 0.60 |
Ventilator Weaning Protocol | 23/36 (64%) | 11/25 (44%) | 0.18 |
VAP Surveillance Guide | 21/36 (58%) | 12/25 (48%) | 0.44 |
VAP Daily Assessment | 17/36 (47%) | 6/25 (24%) | 0.10 |
Ventilator Weaning Protocol (Flowsheet) | 15/36 (42%) | 11/25 (44%) | 0.99 |
Data Tools | 56% | 30% | 0.004 |
QI Implementation Tools | 19/36 (53%) | 6/25 (24%) | 0.03 |
BSI Statistical Process Control | 23/36 (64%) | 5/25 (20%) | 0.001 |
VAP Bundle | 23/36 (64%) | 11/25 (44%) | 0.18 |
VAP Statistical Process Control | 21/36 (58%) | 3/25 (12%) | 0.001 |
Strategies | 69% | 54% | 0.017 |
Protocols for BSI | 24/36 (67%) | 19/25 (76%) | 0.57 |
Protocols for VAP | 22/36 (61%) | 9/25 (36%) | 0.07 |
Computer Documentation for BSI | 24/36 (67%) | 13/25 (52%) | 0.29 |
Computer Documentation for VAP | 25/36 (69%) | 15/25 (60%) | 0.58 |
Increased Staffing | 3/36 (8%) | 0/25 (0%) | 0.26 |
Written Education for BSI | 31/36 (86%) | 19/25 (76%) | 0.33 |
Written Education for VAP | 30/36 (83%) | 19/25 (76%) | 0.52 |
Continuing Education Classes for BSI | 28/36 (78%) | 16/25 (64%) | 0.26 |
Continuing Education Classes for VAP | 30/36 (83%) | 17/25 (68%) | 0.21 |
QI teams | 27/36 (75%) | 14/25 (56%) | 0.16 |
Provider Performance Feedback for BSI | 23/36 (64%) | 11/25 (44%) | 0.18 |
Provider Performance Feedback for VAP | 24/36 (67%) | 11/25 (44%) | 0.11 |
Implementation of BSI Checklist | 28/36 (78%) | 15/25 (60%) | 0.16 |
Implementation of VAP Checklist | 31/36 (86%) | 13/25 (52%) | 0.007 |
Both groups relied primarily on implementation of protocols and informatics approaches (Table 4) without increasing staff levels. The predominant strategy was education; both groups provided written educational materials and classes to their providers. There was a trend for more Collaborative group members to implement QI teams (Table 4, P = 0.16 compared with the Toolkit group). Although the preponderance of both groups provided feedback reports to their hospital leaders and unit managers, Collaborative group hospitals showed a trend for providing feedback to front‐line providers (P = 0.11). With respect to self‐reported interventions, 78% of the Collaborative ICUs reported implementing a CLABSI checklist and 86% a VAP checklist, whereas only 60% of the Toolkit group reported implementation of a CLABSI checklist (P = 0.16) and 52% a VAP checklist (P = 0.007). Once a tool was implemented, both groups reported a high rate of sustaining the implementation (ranging from 86% to 100%). There also seemed to be a pattern of sequencing the interventions. Initial efforts tend to focus on provider education and evidence‐based protocols. Later efforts include more formal formation of QI teams followed by implementation of checklists. The evidence for sequencing of interventions is qualitative; we lacked subgroup sample size to substantiate these results with statistical analysis.
Discussion
In our investigation of Virtual Collaborative and Toolkit strategies for spreading the implementation of safe practices for CLABSI and VAP, ICUs in the Collaborative group had more complete implementation of the processes for prevention of hospital‐associated infections. Although both groups accessed clinical resources consistent with surveillance and clinical education, the Virtual Collaborative group attended to data and implementation methods more likely to lead to systemic CQI and organizational changes. ICUs that engaged these resources believed them useful in implementing QI, and more than 85% of the practices were sustained once integrated into routine care. Although the Collaborative ICUs were about 50% more likely to implement improvement strategies, these differences in implementation and process of care did not translate into group differences or longitudinal changes in infection rates.
In contrast to the context of our investigation, most published QI studies on health careassociated infection prevention report high baseline rates followed by a significant decline in infection rates.1419 The baseline infection rates in our study hospitals were actually below the endpoint found in many prior studies, suggesting that any marginal effects from our intervention would be more difficult to detect. Our study was implemented during the IHI's 100,000 Lives Campaign,20 a trend that may have brought about these lower baseline rates and thus a tighter margin for improvement.
The median CLABSI baseline rate in the well‐publicized Michigan hospital study was 2.7 per 1000 catheter days.21, 22 Although our baseline rate was similar (2.27 per 1000 catheter days), their reported postintervention rate was near zero, inferring nearly total elimination of the risk for CLABSI within 3‐18 months of study implementation. Several other studies using a collaborative approach have similarly reported high‐performance near‐zero results in reducing VAP23, 24 and CLABSI2528 rates. The difference between the present and previously published near‐zero result outcomes raises questions about collaboration‐based studies. We noticed 2 phenomena. First, there was slow uptake of data‐driven QI, and second, there was a differential uptake between general knowledge (clinical evidence and education) and QI implementation knowledge.29, 30
Lack of infrastructure to support data‐driven QI remains a significant barrier throughout the health care system, and teams in collaboratives often must work intensively toward improving their information systems' capability for the purpose of data‐driven decision support.1, 15, 31, 32 Systematic, standardized collection of CLABSI and VAP outcomes was initially lacking in many of our study hospitals,10 and our project expended early effort to deploy a system‐wide standardized infection control database registry.
Both of our study groups gravitated toward educational training and evidence‐based protocol decision‐support strategies. A focus only on established surveillance and education‐based fixes (eg, asking clinicians to follow a protocol within their existing care processes) have produced 32% to 57% reductions in health careacquired infections.3335 These early gains, however, are unlikely to produce the sustained near‐zero results that some collaborative teams have reported.22, 25
The ability to achieve sustained high‐performance results depends on organizational context and requires time.31 A potential benefit of collaboratives might be the return on investment attained by organizational change in quality and safety climate and its influence across the whole organization.19, 31, 36 Participants requiring systems training in the CQI process may not gain these benefits until well into their collaborative.31 For example, accumulating evidence demonstrates that the use of checklists can reduce errors of omission. Although a checklist seems a simple intervention, its effective implementation into routine care processes actually requires time for system redesign that addresses changes in multidisciplinary roles and responsibilities, frontline clinician and mid‐level management buy‐in, new methods of data collection and feedback, unanticipated involvement of ancillary services (eg, medical records, housekeeping), as well as changes to organizational policies, expectations, and priorities that connect silos of care and integrate hierarchical operations. Wall et al.37 and Pronovost and colleagues19, 21, 22, 25 highlighted the strategic effectiveness of embedding a checklist as a behavioral and data collection tool into frontline care process, leading to a redefined role of nursing, as well as new data for further cycles of improvement that collectively reduced infection rates. In our study, the Virtual Collaborative group did not have greater use of CLABSI and VAP checklists until the QI teams had been formed months into the project, consistent with the hypothesis that beneficial translation of desired changes in process of care to observed improvements in patient outcomes may take longer than 18 months to achieve19, 25, 27, 38 as opposed to the remarkable 3 months reported in the Keystone ICU project.21
Our study has several limitations. Our intervention did not mandate fixed specific components of intervention or QI methods. Each medical center was free to tailor its use of tools and change ideas, producing site variation in implementation methods and investment in support of QI. Like other multicomponent, multidimensional intervention studies, we were not able to test the effectiveness of particular QI components or the thoroughness of surveillance for CLABSI and VAP related to efforts to standardize the approach, and we did not have the resources to monitor the intensity with which participants approached QI. Furthermore, our data were dependent on self‐reports and were not verified by independent assessment of the fidelity with which the interventions were implemented, a checklist was embedded into usual care, or practices were enforced by nurses. In addition, the virtual collaborative circumvents the face‐to‐face learning sessions that might play a role in collaborative social networking, peer pressure, and acculturation.31, 36
Despite these limitations, we found that the Virtual Collaborative performed just like a Breakthrough Collaborative with a gradual uptake of implementation science using QI methods, team management, and statistical process control tools. The Toolkit condition had an even slower uptake. From an organization's perspective, the bottom‐line decision is whether a greater and meaningful proportion of collaborative participants will be successful to justify the investment of effort compared to a toolkit‐only approach. Our findings suggest that organizations engaged in change but lacking expertise in implementation science can potentially benefit from the acculturation, experiential learning, and uptake of QI provided by a collaborative.
In summary, although our Virtual Collaborative intervention was more likely to produce changes in ICU processes of care, there were no improvements in patient outcomes over this 18‐month study. The current popularity of evidence‐based guidelines, care protocols, prevention awareness, and surveillance may have produced a background of secular trend, making it difficult to ascertain effects of our QI intervention. Nonetheless, important lessons can be gleaned from this randomized controlled trial. Our study supports the proposition that as long as organizations vary in their capacity for and commitment to the science of QI and systems engineering, we should anticipate variation, uncertainty, and mixed results from short‐term, rapid cycle initiatives.27, 28, 31, 32, 39, 40 The untested, longer‐term benefit produced by a collaborative may be its stimulation of enduring systems engineering that optimizes an environment for QI of health care processes focused on desired outcomes.
Acknowledgements
The authors thank the Agency for Healthcare Research and Quality collaborative investigators for their work in this study: Xu Lei Liu, MS, at Vanderbilt; Laurie Brewer, RN MBA, Jason Hickok, Steve Horner, Susan Littleton, Patsy McFadden, RN BSN MPA CIC, Steve Mok, PharmD, Jonathan Perlin, MD PhD, Joan Reischel, RN BSN CCRN, and Sheri G. Chernestky Tejedor, MD, and all the HCA medical centers that participated in this project.
- Assessing the impact of continuous quality improvement on clinical practice: What it will take to accelerate progress.Milbank Q.1998;76:593–624. , , .
- Continuous improvement as an ideal in health care.N Engl J Med.1989;320:53–56. .
- A framework for collaborative improvement: Lessons from the Institute for Healthcare Improvement's Breakthrough Series.Qual Manag Health Care.1998;6(4):1–13. .
- Quality improvement learning collaboratives.Qual Manag Health Care.2005;14:234–237. , , , , , .
- Using a virtual breakthrough series collaborative to improve access in primary care.Jt Comm J Qual Patient Saf.2006;32:573–584. , , , .
- Taking the national guideline for care of acute myocardial infarction to the bedside: Developing the guideline applied in practice (GAP) initiative in Southeast Michigan.Jt Comm J Qual Improv.2002;28:5–19. , , , et al.
- Priority Areas for National Action: Transforming Health Care Quality.Washington, DC:The National Academies Press;2003. , .
- Optimal multivariate matching before randomization.Biostatistics.2004;5:263–275. , , , .
- Institute for Healthcare Improvement. The 100,000 lives campaign. http://www.ihi.org/IHI/Programs/Campaign.htm;2005.
- Survey of infection control programs in a large, national healthcare system.Infect Control Hosp Epidemiol.2007;28:1401–1403. , , , et al.
- 290–02‐0017 to the Stanford University‐UCSF Evidence‐based Practices Center), 2004. www.ahrq.gov/clinic/tp/qgap1tp.htm. Accessed November 11,2010. , , , . Closing the quality gap: A critical analysis of quality improvement strategies, Volume 1‐Series overview and methodology. Technical Review 9 (Contract No
- Improving safety on the front lines: the role of clinical microsystems.Qual Saf Health Care.2002;11:45–50. , .
- SamplePower 2.0.Chicago, IL:SPSS Inc.;2001. , , .
- Eliminating nosocomial infections at Ascension Health.Jt Comm J Qual Patient Saf.2006;32:612–620. , , , .
- An intensive care unit quality improvement collaborative in nine department of Veterans Affairs hospitals: reducing ventilator‐associated pneumonia and catheter‐related bloodstream infection rates.Jt Comm J Qual Patient Saf.2008;34:639–645. , , , et al.
- Decreasing ventilator‐associated pneumonia in a trauma ICU.J Trauma.2006;61:122–130. , , , et al.
- Use of corporate six sigma performance‐improvement strategies to reduce incidence of catheter‐related bloodstream infections in a surgical ICU.J Am Coll Surg.2005;201:349–358. , , , , , .
- Decline in ICU adverse events, nosocomial infections and cost through a quality improvement initiative focusing on teamwork and culture change.Qual Saf Health Care.2006;15:235–239. , , , , .
- Using a bundle approach to improve ventilator care processes and reduce ventilator‐associated pneumonia.Jt Comm J Qual Patient Saf.2005;31:243–248. , , , , , .
- The 100000 lives campaign: Setting a goal and a deadline for improving health care quality.JAMA.2006;295:324–327. , , , .
- An intervention to decrease catheter‐related bloodstream infections in the ICU.N Engl J Med.2006;355:2725–2732. , , .
- Improving patient safety units in Michigan.J Crit Care.2008;23:207–221. , , , et al.
- Toward a zero VAP rate: Personal and team approaches in the ICU.Crit Care Nurs Q.2006;29:108–114. .
- Implementing a ventilator bundle in a community hospital.Jt Comm J Qual Patient Saf.2007;33:219–225. , , , et al.
- Eliminating catheter‐realted bloodstream infections in the intensive care unit.Crit Care Med.2004;32:2014–2020. , , , et al.
- Innovative bundle wipes out catheter‐related bloodstream infections.Nursing.2008;38:17–18. .
- The CLABs collaborative: a regionwide effort to improve the quality of care in hospitals.Jt Comm J Qual Patient Saf.2008;34:713–723. , , , , , .
- Evidence‐based practice to reduce central line infections.Jt Comm J Qual Patient Saf.2006;32:253–260. , , , et al.
- Learning and improving in quality improvement collaboratives: which collaborative features do participants value most?Health Serv Res.2009;44(2 Pt 1):359–378. .
- Inside the health disparities collaboratives: a detailed exploration of quality improvement at community health centers.Med Care.2008;46:489–496. , , , et al.
- Quality collaboratives: lessons from research.Qual Saf Health Care.2002;11:345–351. , , , et al.
- Assessing the implementation of the chronic care model in quality improvement collaboratives.Health Serv Res.2005;40:978–996. , , , et al.
- Prevention of ventilator‐associated pneumonia: Analysis of studies published since 2004.J Hosp Infect.2007;67:1–8. , .
- Effect of comparative data feedback on intensive care unit infection rates in a Veterans Administration Hospital network system.Am J Infect Control.2003;31:397–404. , , , .
- Reducing ventilator‐associated pneumonia rates through a staff education programme.J Hosp Infect.2004;57:223–227. , , , et al.
- Does quality improvement implementation affect hospital quality of care?Hosp Top.2007;85:3–12. , , , .
- Using real‐time process measurements to reduce catheter‐related bloodstream infections in the intensive care unit.Qual Saf Health Care.2005;14:295–302. , , , , , .
- Prevention of ventilator‐associated pneumonia in the Calgary health region: a Canadian success story!Healthcare Qual.2008;11(3 Spec No):129–136. , , , , , .
- Creating the evidence base for quality improvement collaboratives.Ann Intern Med.2004;140:897–901. .
- Evidence for the impact of quality improvement collaboratives: systematic review.Br Med J.2008;336:1491–1494. , , , , .
Continuous quality improvement (CQI) methodologies provide a framework for initiating and sustaining improvements in complex systems.1 By definition, CQI engages frontline staff in iterative problem solving using plandostudyact cycles of learning, with decision‐making based on real‐time process measurements.2 The Institute for Healthcare Improvement (IHI) has sponsored Breakthrough Series Collaboratives since 1996 to accelerate the uptake and impact of quality improvement (QI).3, 4 These collaboratives are typically guided by evidence‐based clinical practice guidelines, incorporate change methodologies, and rely on clinical and process improvement subject matter experts. Through the collaborative network, teams share knowledge and ideas about effective and ineffective interventions as well as strategies for overcoming barriers. The collaborative curriculum includes CQI methodology, multidisciplinary teamwork, leadership support, and tools for measurement. Participants are typically required to invest resources and send teams to face‐to‐face goal‐oriented meetings. It is costly for a large healthcare organization to incorporate travel to a learning session conference into its collaborative model. Thus, we attempted virtual learning sessions that make use of webcasts, a Web site, and teleconference calls for tools and networking.5
A recent derivative of collaboratives has been deployment of toolkits for QI. Intuition suggests that such toolkits may help to enable change, and thus some agencies advocate the simpler approach of disseminating toolkits as a change strategy.6 Toolkit dissemination is a passive approach in contrast to collaborative participation, and its effectiveness has not been critically examined in evidence‐based literature.
We sought to compare the virtual collaborative model with the toolkit model for improving care. Recommendations and guidelines for central lineassociated bloodstream infection (CLABSI) and ventilator‐associated pneumonia (VAP) prevention have not been implemented reliably, resulting in unnecessary intensive care unit (ICU) morbidity and mortality and fostering a national call for improvement.7 Our aim was to compare the effectiveness of the virtual collaborative and toolkit approaches on preventing CLABSI and VAP in the ICU.
Methods
This cluster randomized trial included medical centers within the Hospital Corporation of America (HCA), a network of hospitals located primarily in the southern United States. To minimize contamination bias between study groups within the same facility, the unit of randomization was the hospital and implementation was at the level of the ICU. The project received approval from the Vanderbilt University Institutional Review Board.
Leaders of all medical centers with at least 1 adult or pediatric ICU received an invitation from HCA leadership to participate in a QI initiative. Facility clinicians and managers completed baseline surveys (shown in the Supporting Information) on hospital characteristics, types of ICUs, patient safety climate, and QI resources between July and November 2005. Hospital‐level data were extracted from the enterprise‐wide data warehouse. Hospitals willing to participate were matched on geographic location and ICU volume and then randomized into either the Virtual Collaborative (n = 31) or Toolkit (n = 30) groups in December 20058; 1 of the hospitals was sold, yielding 29 hospitals in the Toolkit (n = 29) group. The study lasted 18 months from January 2006 through September 2007, with health careassociated infection data collected through December 2007, and follow‐up data collection through April 2008.
The QI initiative included educational opportunities, evidence‐based clinical prevention interventions, and processes and tools to implement and measure the impact of these interventions. Participants in both groups were offered interactive Web seminars during the study period; 5 of these seminars were on clinical subject matter, and 5 seminars were on patient safety, charting use of statistical process control and QI methods. The interventions were evidence‐based care bundles.9 The key interventions for preventing CLABSI were routine hand hygiene, use of chlorhexidine skin antisepsis, maximal barrier precautions during catheter insertion, catheter site and care, and avoidance of routine replacement of catheters. The key interventions to prevent VAP were routine elevation of head of the bed, regular oral care, daily sedation vacations, daily assessment of readiness to extubate, secretion cleaning, peptic ulcer disease prophylaxis, and deep vein thrombosis prophylaxis.
Toolkit Group
Hospitals randomized to this arm received a toolkit during study month 1 containing a set of evidence‐based guidelines and fact sheets for preventing CLABSI and VAP, a review of QI and teamwork methods, standardized data collection tools, and standardized charting tools. The nurse and quality managers for the Toolkit ICUs were provided ad libitum access to the HCA intranet toolkit Web site containing all of the educational seminars, clinical tools, and QI tools. Otherwise, ICUs in this group were on their own to initiate and implement a local hospital QI initiative to prevent CLABSI and VAP.
Virtual Collaborative Group
In addition to the materials and Web site support described above, facility leaders and managers in this Virtual Collaborative group agreed to participate in a virtual collaborative to develop processes to more reliably implement evidence‐based interventions to prevent CLABSI and VAP. The collaboration differed from the Breakthrough Series model3, 4 in that teams did not come together for face‐to‐face educational and planning sessions but instead attended Web seminars and teleconferences for reporting back to the larger group.5 Teams were supported through monthly educational and troubleshooting conference calls, individual coaching coordinated by the HCA corporate office of quality, safety, and performance improvement, and an e‐mail listserv designed to stimulate interaction among teams.
Clinical Outcome Measures
Although most participating hospitals defined CLABSI and VAP using the Centers for Disease Control and Prevention definitions, data collection and surveillance methods varied across hospitals.10 Education was provided to standardize outcome measurement. A data registry Web application was created as a new tool for infection control data entry, and healthcare‐associated infection data reporting by the infection control personnel was mandated starting the first quarter of 2006. To verify electronic data and correct missing information, the infection control personnel were requested to complete a retrospective data collection sheet providing quarterly reports from January 2005 through December 2007 on ICU infection events as well as total catheter days and ventilator days to allow calculation of event rates. Outcome measures of CLABSI and VAP were at the level of the hospital.
Follow‐Up
The HCA e‐mail distribution and collection routine was employed for the follow‐up survey of ICU nurse and quality managers for all participating medical centers from January 2008 through April 2008. A single survey (shown in the Supporting Information) was requested from each participating ICU. The ICU‐level surveys included questions about the implementation of the CLABSI and VAP process interventions, access of tools, participation in Web seminars, and use of QI strategies.11, 12 The postintervention survey also assessed the character and amount of implementation and teamwork activity expended.
Median CLABSI and VAP rates for a 3‐month baseline and quarterly postintervention periods were compared between the 2 study groups. The CLABSI and VAP infection rates were also analyzed using hierarchical negative binomial regression models to model infection rate changes over time (time in months and group by time interaction effects) and account for clustering of ICUs within hospitals and adjusting for baseline covariates. Baseline and process variables at the hospital and ICU level were compared using chi‐square tests and t tests according to the type of measurement. Time‐to‐event analyses were conducted to compare the groups on time to initiation of a care process. All analyses were conducted using the (R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria, 2010).
The power of the study was calculated a priori with a 1‐tailed alpha of 0.05 and group size of 30. We hypothesized a 50% decrease in hospital‐associated infection rates for the Collaborative group vs. a 10% to 15% decrease for the Toolkit group. The calculations yielded power ranging from a low of 82% to a high of 91% for testing group differences.13
Results
Participating facilities included rural (11%), inner city (28%), and suburban (61%) medical centers. The 60 participating sites did not differ in administrative variables from the 113 nonparticipating HCA sites (results not shown). The median hospital size was 177 beds and the median ICU size was 16 beds. The hospitals did not differ between study groups (Table 1). At baseline, 45% of the facilities reported having a CLABSI program and 62% a VAP program.
Hospital Factors at Baseline | Virtual Collaborative | Toolkit | P Value |
---|---|---|---|
| |||
Number of hospitals | 31 | 29* | |
ICU annual patient volume, median (IQR) | 568 (294, 904) | 578 (244, 1077) | 0.93 |
ICU patient length of stay days, median (IQR) | 3882 (1758, 5718) | 4228 (1645, 6725) | 0.95 |
ICU mortality rate, percent (SD) | 5.7% (3.1%) | 7.1% (3.6%) | 0.13 |
Medicare/Medicaid, percent (SD) | 68.6% (9.5%) | 68.5% (10.1%) | 0.95 |
Percent admitted to ICU from the Emergency Department (SD) | 71% (15%) | 67% (20%) | 0.27 |
Percent female (SD) | 49.7% (5.7%) | 50.3% (7.7%) | 0.79 |
Medicare case‐mix weight, mean (SD) | 1221 (1007) | 1295 (1110) | 0.82 |
Percent hospitalist ICU management | 47% | 40% | 0.61 |
The baseline and quarterly median and pooled infection rates for the Toolkit and Collaboration groups are shown in Table 2 for CLABSI and in Table 3 for VAP. There were no significant differences in the baseline rates for either CLABSI (P = 0.24) or VAP (P = 0.72) between the Collaborative and Toolkit groups. There was no significant change for either CLABSI or VAP outcomes at either 12 or 18 months of follow‐up. The median bloodstream infection rate for all participating hospitals was 2.27 at baseline, 1.18 at 12 months (P = 0.13), and 2.23 per 1000 catheter days 18 months later (P = 0.95). The median VAP rate for participating hospitals was 2.90 at baseline, 2.67 at 12 months (P = 0.44), and 2.52 per 1000 ventilator days 18 months later (P = 0.84). The hierarchical regression analysis found that neither the Collaborative nor Toolkit groups improved CLABSI (P = 0.75 and P = 0.83, respectively) or VAP (P = 0.61 and P = 0.37, respectively) rates over time, and there was no differential performance between the 2 groups for either outcome (bloodstream infection, P = 0.71; VAP, P = 0.80).
Overall | Virtual Collaborative | Toolkit | ||||
---|---|---|---|---|---|---|
N = 59 Hospitals | N = 30 Hospitals | N = 29 Hospitals | ||||
Study Period | Hospital Median (IQR) | Rate Pooled Across Hospitals | Hospital Median (IQR) | Rate Pooled Across Hospitals | Hospital Median (IQR) | Rate Pooled Across Hospitals |
| ||||||
Baseline | 2.27 (0.00‐3.98) | 2.42 | 1.84 (0.00‐3.83) | 1.67 | 2.42 (0.65‐6.80) | 3.05 |
3 Month | 2.27 (1.30‐4.69) | 2.61 | 2.24 (0.54‐4.69) | 2.34 | 2.47 (1.48‐5.35) | 2.85 |
6 Month | 2.37 (0.00‐4.29) | 2.73 | 2.28 (0.00‐3.73) | 2.35 | 2.54 (0.00‐4.98) | 3.09 |
9 Month | 1.66 (0.00‐3.84) | 2.45 | 1.76 (0.00‐3.74) | 2.28 | 1.23 (0.00‐3.93) | 2.59 |
12 Month | 1.18 (0.00‐3.10) | 2.17 | 1.18 (0.00‐2.71) | 1.72 | 1.17 (0.00‐3.61) | 2.58 |
15 Month | 1.93 (0.00‐4.25) | 2.29 | 2.04 (0.00‐4.91) | 2.53 | 1.77 (0.00‐3.30) | 2.08 |
18 Month | 2.23 (0.00‐4.97) | 2.73 | 2.76 (0.00‐4.67) | 2.75 | 1.16 (0.00‐5.46) | 2.72 |
Study Period | Overall | Virtual Collaborative | Toolkit | |||
---|---|---|---|---|---|---|
N = 59 Hospitals | N = 30 Hospitals | N = 29 Hospitals | ||||
Hospital Median (IQR) | Rate Pooled Across Hospitals | Hospital Median (IQR) | Rate Pooled Across Hospitals | Hospital Median (IQR) | Rate Pooled Across Hospitals | |
| ||||||
Baseline | 2.90 (0.00‐6.14) | 3.97 | 2.14 (0.00‐6.09) | 3.43 | 3.49 (0.00‐7.04) | 4.36 |
3 Month | 3.12 (0.00‐8.40) | 4.46 | 3.01 (0.00‐9.11) | 4.22 | 3.32 (0.00‐8.25) | 4.62 |
6 Month | 3.40 (0.00‐7.53) | 4.97 | 2.72 (0.00‐7.09) | 4.81 | 4.61 (0.00‐9.37) | 5.10 |
9 Month | 1.49 (0.00‐4.87) | 2.99 | 0 (0.00‐3.94) | 2.51 | 2.27 (0.00‐6.27) | 3.36 |
12 Month | 2.67 (0.00‐4.60) | 4.39 | 2.67 (0.00‐4.47) | 3.82 | 2.66 (0.00‐4.82) | 4.95 |
15 Month | 3.06 (0.00‐5.10) | 4.03 | 2.40 (0.00‐3.94) | 3.57 | 3.65 (1.15‐6.57) | 4.45 |
18 Month | 2.52 (0.00‐7.45) | 4.61 | 2.93 (0.00‐7.63) | 5.02 | 2.06 (0.00‐6.59) | 4.31 |
The poststudy survey was completed by 27 of 31 (87%) of Collaborative group hospitals and 19 of the 29 (66%) Toolkit hospitals. Both groups reported QI improvement efforts to prevent CLABSI (Collaborative 97% vs. Toolkit 88%, P = 0.29) and VAP (Collaborative 97% vs. Toolkit 96%, P = 0.99). Eighty‐three percent of the Collaborative group implemented all components of the bloodstream infection prevention interventions compared with 64% for the Toolkit group (P = 0.13; Figure 1). The Collaborative group implemented daily catheter review more often than the Toolkit group (P = 0.04) and began the process implementation sooner following study implementation (P = 0.006 vs. Toolkit; see Supporting Information Figure). Eighty‐six percent of the Collaborative group implemented the complete VAP prevention interventions vs. 64% of the Toolkit group (P = 0.06; Figure 1) and the Collaborative group conducted the sedation vacation intervention more often (P = 0.03).

The Collaborative group participated in 57% of the seminars, whereas the Toolkit group participated in 39% (P = 0.014). Members of both groups attended more than half the clinical topics (Collaborative 64% vs. Toolkit 56%, P = 0.37). The Collaborative group had greater participation in the data and method topics (Collaborative 50% vs. Toolkit 22%, P < 0.001). The proportion of hospitals finding the seminars useful to their QI efforts was 49% for the Collaborative and 30% for the Toolkit group (P = 0.017). When restricted to hospitals that participated in the seminars, the usefulness rating was higher for both clinical (91% for the Collaborative and 86% for Toolkit) and Data/Methods (79% for Collaborative and 55% for Toolkit) topics.
A set of 14 tools were produced during the study period (Table 4); 9 clinically related tools (eg, checklists, algorithms, protocols, and flowsheets) and 5 data monitoring and quality improvement tools (eg, easy‐to‐use statistical process control spreadsheet templates, quality improvement tools, and computer tools). The Collaborative group downloaded a median of 10 tools and the Toolkit group a median of 7 (P = 0.051). The groups did not differ in their access to the clinical tools (P = 0.23) but the Collaborative group accessed a greater proportion of the data/methods tools (P = 0.004).
Tool Access and Strategies | Collaborative Hospitalsa | Tool Kit Hospitalsa | P‐value |
---|---|---|---|
N = 36 ICUs | N = 25 ICUs | ||
| |||
Clinical Tool Use | 61% | 49% | 0.23 |
BSI Surveillance Guide | 22/36 (61%) | 13/25 (52%) | 0.60 |
BSI Checklist | 31/36 (86%) | 16/25 (64%) | 0.06 |
VAP Diagnosis Algorithm | 24/36 (67%) | 15/25 (60%) | 0.60 |
Ventilator Weaning Protocol | 23/36 (64%) | 11/25 (44%) | 0.18 |
VAP Surveillance Guide | 21/36 (58%) | 12/25 (48%) | 0.44 |
VAP Daily Assessment | 17/36 (47%) | 6/25 (24%) | 0.10 |
Ventilator Weaning Protocol (Flowsheet) | 15/36 (42%) | 11/25 (44%) | 0.99 |
Data Tools | 56% | 30% | 0.004 |
QI Implementation Tools | 19/36 (53%) | 6/25 (24%) | 0.03 |
BSI Statistical Process Control | 23/36 (64%) | 5/25 (20%) | 0.001 |
VAP Bundle | 23/36 (64%) | 11/25 (44%) | 0.18 |
VAP Statistical Process Control | 21/36 (58%) | 3/25 (12%) | 0.001 |
Strategies | 69% | 54% | 0.017 |
Protocols for BSI | 24/36 (67%) | 19/25 (76%) | 0.57 |
Protocols for VAP | 22/36 (61%) | 9/25 (36%) | 0.07 |
Computer Documentation for BSI | 24/36 (67%) | 13/25 (52%) | 0.29 |
Computer Documentation for VAP | 25/36 (69%) | 15/25 (60%) | 0.58 |
Increased Staffing | 3/36 (8%) | 0/25 (0%) | 0.26 |
Written Education for BSI | 31/36 (86%) | 19/25 (76%) | 0.33 |
Written Education for VAP | 30/36 (83%) | 19/25 (76%) | 0.52 |
Continuing Education Classes for BSI | 28/36 (78%) | 16/25 (64%) | 0.26 |
Continuing Education Classes for VAP | 30/36 (83%) | 17/25 (68%) | 0.21 |
QI teams | 27/36 (75%) | 14/25 (56%) | 0.16 |
Provider Performance Feedback for BSI | 23/36 (64%) | 11/25 (44%) | 0.18 |
Provider Performance Feedback for VAP | 24/36 (67%) | 11/25 (44%) | 0.11 |
Implementation of BSI Checklist | 28/36 (78%) | 15/25 (60%) | 0.16 |
Implementation of VAP Checklist | 31/36 (86%) | 13/25 (52%) | 0.007 |
Both groups relied primarily on implementation of protocols and informatics approaches (Table 4) without increasing staff levels. The predominant strategy was education; both groups provided written educational materials and classes to their providers. There was a trend for more Collaborative group members to implement QI teams (Table 4, P = 0.16 compared with the Toolkit group). Although the preponderance of both groups provided feedback reports to their hospital leaders and unit managers, Collaborative group hospitals showed a trend for providing feedback to front‐line providers (P = 0.11). With respect to self‐reported interventions, 78% of the Collaborative ICUs reported implementing a CLABSI checklist and 86% a VAP checklist, whereas only 60% of the Toolkit group reported implementation of a CLABSI checklist (P = 0.16) and 52% a VAP checklist (P = 0.007). Once a tool was implemented, both groups reported a high rate of sustaining the implementation (ranging from 86% to 100%). There also seemed to be a pattern of sequencing the interventions. Initial efforts tend to focus on provider education and evidence‐based protocols. Later efforts include more formal formation of QI teams followed by implementation of checklists. The evidence for sequencing of interventions is qualitative; we lacked subgroup sample size to substantiate these results with statistical analysis.
Discussion
In our investigation of Virtual Collaborative and Toolkit strategies for spreading the implementation of safe practices for CLABSI and VAP, ICUs in the Collaborative group had more complete implementation of the processes for prevention of hospital‐associated infections. Although both groups accessed clinical resources consistent with surveillance and clinical education, the Virtual Collaborative group attended to data and implementation methods more likely to lead to systemic CQI and organizational changes. ICUs that engaged these resources believed them useful in implementing QI, and more than 85% of the practices were sustained once integrated into routine care. Although the Collaborative ICUs were about 50% more likely to implement improvement strategies, these differences in implementation and process of care did not translate into group differences or longitudinal changes in infection rates.
In contrast to the context of our investigation, most published QI studies on health careassociated infection prevention report high baseline rates followed by a significant decline in infection rates.1419 The baseline infection rates in our study hospitals were actually below the endpoint found in many prior studies, suggesting that any marginal effects from our intervention would be more difficult to detect. Our study was implemented during the IHI's 100,000 Lives Campaign,20 a trend that may have brought about these lower baseline rates and thus a tighter margin for improvement.
The median CLABSI baseline rate in the well‐publicized Michigan hospital study was 2.7 per 1000 catheter days.21, 22 Although our baseline rate was similar (2.27 per 1000 catheter days), their reported postintervention rate was near zero, inferring nearly total elimination of the risk for CLABSI within 3‐18 months of study implementation. Several other studies using a collaborative approach have similarly reported high‐performance near‐zero results in reducing VAP23, 24 and CLABSI2528 rates. The difference between the present and previously published near‐zero result outcomes raises questions about collaboration‐based studies. We noticed 2 phenomena. First, there was slow uptake of data‐driven QI, and second, there was a differential uptake between general knowledge (clinical evidence and education) and QI implementation knowledge.29, 30
Lack of infrastructure to support data‐driven QI remains a significant barrier throughout the health care system, and teams in collaboratives often must work intensively toward improving their information systems' capability for the purpose of data‐driven decision support.1, 15, 31, 32 Systematic, standardized collection of CLABSI and VAP outcomes was initially lacking in many of our study hospitals,10 and our project expended early effort to deploy a system‐wide standardized infection control database registry.
Both of our study groups gravitated toward educational training and evidence‐based protocol decision‐support strategies. A focus only on established surveillance and education‐based fixes (eg, asking clinicians to follow a protocol within their existing care processes) have produced 32% to 57% reductions in health careacquired infections.3335 These early gains, however, are unlikely to produce the sustained near‐zero results that some collaborative teams have reported.22, 25
The ability to achieve sustained high‐performance results depends on organizational context and requires time.31 A potential benefit of collaboratives might be the return on investment attained by organizational change in quality and safety climate and its influence across the whole organization.19, 31, 36 Participants requiring systems training in the CQI process may not gain these benefits until well into their collaborative.31 For example, accumulating evidence demonstrates that the use of checklists can reduce errors of omission. Although a checklist seems a simple intervention, its effective implementation into routine care processes actually requires time for system redesign that addresses changes in multidisciplinary roles and responsibilities, frontline clinician and mid‐level management buy‐in, new methods of data collection and feedback, unanticipated involvement of ancillary services (eg, medical records, housekeeping), as well as changes to organizational policies, expectations, and priorities that connect silos of care and integrate hierarchical operations. Wall et al.37 and Pronovost and colleagues19, 21, 22, 25 highlighted the strategic effectiveness of embedding a checklist as a behavioral and data collection tool into frontline care process, leading to a redefined role of nursing, as well as new data for further cycles of improvement that collectively reduced infection rates. In our study, the Virtual Collaborative group did not have greater use of CLABSI and VAP checklists until the QI teams had been formed months into the project, consistent with the hypothesis that beneficial translation of desired changes in process of care to observed improvements in patient outcomes may take longer than 18 months to achieve19, 25, 27, 38 as opposed to the remarkable 3 months reported in the Keystone ICU project.21
Our study has several limitations. Our intervention did not mandate fixed specific components of intervention or QI methods. Each medical center was free to tailor its use of tools and change ideas, producing site variation in implementation methods and investment in support of QI. Like other multicomponent, multidimensional intervention studies, we were not able to test the effectiveness of particular QI components or the thoroughness of surveillance for CLABSI and VAP related to efforts to standardize the approach, and we did not have the resources to monitor the intensity with which participants approached QI. Furthermore, our data were dependent on self‐reports and were not verified by independent assessment of the fidelity with which the interventions were implemented, a checklist was embedded into usual care, or practices were enforced by nurses. In addition, the virtual collaborative circumvents the face‐to‐face learning sessions that might play a role in collaborative social networking, peer pressure, and acculturation.31, 36
Despite these limitations, we found that the Virtual Collaborative performed just like a Breakthrough Collaborative with a gradual uptake of implementation science using QI methods, team management, and statistical process control tools. The Toolkit condition had an even slower uptake. From an organization's perspective, the bottom‐line decision is whether a greater and meaningful proportion of collaborative participants will be successful to justify the investment of effort compared to a toolkit‐only approach. Our findings suggest that organizations engaged in change but lacking expertise in implementation science can potentially benefit from the acculturation, experiential learning, and uptake of QI provided by a collaborative.
In summary, although our Virtual Collaborative intervention was more likely to produce changes in ICU processes of care, there were no improvements in patient outcomes over this 18‐month study. The current popularity of evidence‐based guidelines, care protocols, prevention awareness, and surveillance may have produced a background of secular trend, making it difficult to ascertain effects of our QI intervention. Nonetheless, important lessons can be gleaned from this randomized controlled trial. Our study supports the proposition that as long as organizations vary in their capacity for and commitment to the science of QI and systems engineering, we should anticipate variation, uncertainty, and mixed results from short‐term, rapid cycle initiatives.27, 28, 31, 32, 39, 40 The untested, longer‐term benefit produced by a collaborative may be its stimulation of enduring systems engineering that optimizes an environment for QI of health care processes focused on desired outcomes.
Acknowledgements
The authors thank the Agency for Healthcare Research and Quality collaborative investigators for their work in this study: Xu Lei Liu, MS, at Vanderbilt; Laurie Brewer, RN MBA, Jason Hickok, Steve Horner, Susan Littleton, Patsy McFadden, RN BSN MPA CIC, Steve Mok, PharmD, Jonathan Perlin, MD PhD, Joan Reischel, RN BSN CCRN, and Sheri G. Chernestky Tejedor, MD, and all the HCA medical centers that participated in this project.
Continuous quality improvement (CQI) methodologies provide a framework for initiating and sustaining improvements in complex systems.1 By definition, CQI engages frontline staff in iterative problem solving using plandostudyact cycles of learning, with decision‐making based on real‐time process measurements.2 The Institute for Healthcare Improvement (IHI) has sponsored Breakthrough Series Collaboratives since 1996 to accelerate the uptake and impact of quality improvement (QI).3, 4 These collaboratives are typically guided by evidence‐based clinical practice guidelines, incorporate change methodologies, and rely on clinical and process improvement subject matter experts. Through the collaborative network, teams share knowledge and ideas about effective and ineffective interventions as well as strategies for overcoming barriers. The collaborative curriculum includes CQI methodology, multidisciplinary teamwork, leadership support, and tools for measurement. Participants are typically required to invest resources and send teams to face‐to‐face goal‐oriented meetings. It is costly for a large healthcare organization to incorporate travel to a learning session conference into its collaborative model. Thus, we attempted virtual learning sessions that make use of webcasts, a Web site, and teleconference calls for tools and networking.5
A recent derivative of collaboratives has been deployment of toolkits for QI. Intuition suggests that such toolkits may help to enable change, and thus some agencies advocate the simpler approach of disseminating toolkits as a change strategy.6 Toolkit dissemination is a passive approach in contrast to collaborative participation, and its effectiveness has not been critically examined in evidence‐based literature.
We sought to compare the virtual collaborative model with the toolkit model for improving care. Recommendations and guidelines for central lineassociated bloodstream infection (CLABSI) and ventilator‐associated pneumonia (VAP) prevention have not been implemented reliably, resulting in unnecessary intensive care unit (ICU) morbidity and mortality and fostering a national call for improvement.7 Our aim was to compare the effectiveness of the virtual collaborative and toolkit approaches on preventing CLABSI and VAP in the ICU.
Methods
This cluster randomized trial included medical centers within the Hospital Corporation of America (HCA), a network of hospitals located primarily in the southern United States. To minimize contamination bias between study groups within the same facility, the unit of randomization was the hospital and implementation was at the level of the ICU. The project received approval from the Vanderbilt University Institutional Review Board.
Leaders of all medical centers with at least 1 adult or pediatric ICU received an invitation from HCA leadership to participate in a QI initiative. Facility clinicians and managers completed baseline surveys (shown in the Supporting Information) on hospital characteristics, types of ICUs, patient safety climate, and QI resources between July and November 2005. Hospital‐level data were extracted from the enterprise‐wide data warehouse. Hospitals willing to participate were matched on geographic location and ICU volume and then randomized into either the Virtual Collaborative (n = 31) or Toolkit (n = 30) groups in December 20058; 1 of the hospitals was sold, yielding 29 hospitals in the Toolkit (n = 29) group. The study lasted 18 months from January 2006 through September 2007, with health careassociated infection data collected through December 2007, and follow‐up data collection through April 2008.
The QI initiative included educational opportunities, evidence‐based clinical prevention interventions, and processes and tools to implement and measure the impact of these interventions. Participants in both groups were offered interactive Web seminars during the study period; 5 of these seminars were on clinical subject matter, and 5 seminars were on patient safety, charting use of statistical process control and QI methods. The interventions were evidence‐based care bundles.9 The key interventions for preventing CLABSI were routine hand hygiene, use of chlorhexidine skin antisepsis, maximal barrier precautions during catheter insertion, catheter site and care, and avoidance of routine replacement of catheters. The key interventions to prevent VAP were routine elevation of head of the bed, regular oral care, daily sedation vacations, daily assessment of readiness to extubate, secretion cleaning, peptic ulcer disease prophylaxis, and deep vein thrombosis prophylaxis.
Toolkit Group
Hospitals randomized to this arm received a toolkit during study month 1 containing a set of evidence‐based guidelines and fact sheets for preventing CLABSI and VAP, a review of QI and teamwork methods, standardized data collection tools, and standardized charting tools. The nurse and quality managers for the Toolkit ICUs were provided ad libitum access to the HCA intranet toolkit Web site containing all of the educational seminars, clinical tools, and QI tools. Otherwise, ICUs in this group were on their own to initiate and implement a local hospital QI initiative to prevent CLABSI and VAP.
Virtual Collaborative Group
In addition to the materials and Web site support described above, facility leaders and managers in this Virtual Collaborative group agreed to participate in a virtual collaborative to develop processes to more reliably implement evidence‐based interventions to prevent CLABSI and VAP. The collaboration differed from the Breakthrough Series model3, 4 in that teams did not come together for face‐to‐face educational and planning sessions but instead attended Web seminars and teleconferences for reporting back to the larger group.5 Teams were supported through monthly educational and troubleshooting conference calls, individual coaching coordinated by the HCA corporate office of quality, safety, and performance improvement, and an e‐mail listserv designed to stimulate interaction among teams.
Clinical Outcome Measures
Although most participating hospitals defined CLABSI and VAP using the Centers for Disease Control and Prevention definitions, data collection and surveillance methods varied across hospitals.10 Education was provided to standardize outcome measurement. A data registry Web application was created as a new tool for infection control data entry, and healthcare‐associated infection data reporting by the infection control personnel was mandated starting the first quarter of 2006. To verify electronic data and correct missing information, the infection control personnel were requested to complete a retrospective data collection sheet providing quarterly reports from January 2005 through December 2007 on ICU infection events as well as total catheter days and ventilator days to allow calculation of event rates. Outcome measures of CLABSI and VAP were at the level of the hospital.
Follow‐Up
The HCA e‐mail distribution and collection routine was employed for the follow‐up survey of ICU nurse and quality managers for all participating medical centers from January 2008 through April 2008. A single survey (shown in the Supporting Information) was requested from each participating ICU. The ICU‐level surveys included questions about the implementation of the CLABSI and VAP process interventions, access of tools, participation in Web seminars, and use of QI strategies.11, 12 The postintervention survey also assessed the character and amount of implementation and teamwork activity expended.
Median CLABSI and VAP rates for a 3‐month baseline and quarterly postintervention periods were compared between the 2 study groups. The CLABSI and VAP infection rates were also analyzed using hierarchical negative binomial regression models to model infection rate changes over time (time in months and group by time interaction effects) and account for clustering of ICUs within hospitals and adjusting for baseline covariates. Baseline and process variables at the hospital and ICU level were compared using chi‐square tests and t tests according to the type of measurement. Time‐to‐event analyses were conducted to compare the groups on time to initiation of a care process. All analyses were conducted using the (R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria, 2010).
The power of the study was calculated a priori with a 1‐tailed alpha of 0.05 and group size of 30. We hypothesized a 50% decrease in hospital‐associated infection rates for the Collaborative group vs. a 10% to 15% decrease for the Toolkit group. The calculations yielded power ranging from a low of 82% to a high of 91% for testing group differences.13
Results
Participating facilities included rural (11%), inner city (28%), and suburban (61%) medical centers. The 60 participating sites did not differ in administrative variables from the 113 nonparticipating HCA sites (results not shown). The median hospital size was 177 beds and the median ICU size was 16 beds. The hospitals did not differ between study groups (Table 1). At baseline, 45% of the facilities reported having a CLABSI program and 62% a VAP program.
Hospital Factors at Baseline | Virtual Collaborative | Toolkit | P Value |
---|---|---|---|
| |||
Number of hospitals | 31 | 29* | |
ICU annual patient volume, median (IQR) | 568 (294, 904) | 578 (244, 1077) | 0.93 |
ICU patient length of stay days, median (IQR) | 3882 (1758, 5718) | 4228 (1645, 6725) | 0.95 |
ICU mortality rate, percent (SD) | 5.7% (3.1%) | 7.1% (3.6%) | 0.13 |
Medicare/Medicaid, percent (SD) | 68.6% (9.5%) | 68.5% (10.1%) | 0.95 |
Percent admitted to ICU from the Emergency Department (SD) | 71% (15%) | 67% (20%) | 0.27 |
Percent female (SD) | 49.7% (5.7%) | 50.3% (7.7%) | 0.79 |
Medicare case‐mix weight, mean (SD) | 1221 (1007) | 1295 (1110) | 0.82 |
Percent hospitalist ICU management | 47% | 40% | 0.61 |
The baseline and quarterly median and pooled infection rates for the Toolkit and Collaboration groups are shown in Table 2 for CLABSI and in Table 3 for VAP. There were no significant differences in the baseline rates for either CLABSI (P = 0.24) or VAP (P = 0.72) between the Collaborative and Toolkit groups. There was no significant change for either CLABSI or VAP outcomes at either 12 or 18 months of follow‐up. The median bloodstream infection rate for all participating hospitals was 2.27 at baseline, 1.18 at 12 months (P = 0.13), and 2.23 per 1000 catheter days 18 months later (P = 0.95). The median VAP rate for participating hospitals was 2.90 at baseline, 2.67 at 12 months (P = 0.44), and 2.52 per 1000 ventilator days 18 months later (P = 0.84). The hierarchical regression analysis found that neither the Collaborative nor Toolkit groups improved CLABSI (P = 0.75 and P = 0.83, respectively) or VAP (P = 0.61 and P = 0.37, respectively) rates over time, and there was no differential performance between the 2 groups for either outcome (bloodstream infection, P = 0.71; VAP, P = 0.80).
Overall | Virtual Collaborative | Toolkit | ||||
---|---|---|---|---|---|---|
N = 59 Hospitals | N = 30 Hospitals | N = 29 Hospitals | ||||
Study Period | Hospital Median (IQR) | Rate Pooled Across Hospitals | Hospital Median (IQR) | Rate Pooled Across Hospitals | Hospital Median (IQR) | Rate Pooled Across Hospitals |
| ||||||
Baseline | 2.27 (0.00‐3.98) | 2.42 | 1.84 (0.00‐3.83) | 1.67 | 2.42 (0.65‐6.80) | 3.05 |
3 Month | 2.27 (1.30‐4.69) | 2.61 | 2.24 (0.54‐4.69) | 2.34 | 2.47 (1.48‐5.35) | 2.85 |
6 Month | 2.37 (0.00‐4.29) | 2.73 | 2.28 (0.00‐3.73) | 2.35 | 2.54 (0.00‐4.98) | 3.09 |
9 Month | 1.66 (0.00‐3.84) | 2.45 | 1.76 (0.00‐3.74) | 2.28 | 1.23 (0.00‐3.93) | 2.59 |
12 Month | 1.18 (0.00‐3.10) | 2.17 | 1.18 (0.00‐2.71) | 1.72 | 1.17 (0.00‐3.61) | 2.58 |
15 Month | 1.93 (0.00‐4.25) | 2.29 | 2.04 (0.00‐4.91) | 2.53 | 1.77 (0.00‐3.30) | 2.08 |
18 Month | 2.23 (0.00‐4.97) | 2.73 | 2.76 (0.00‐4.67) | 2.75 | 1.16 (0.00‐5.46) | 2.72 |
Study Period | Overall | Virtual Collaborative | Toolkit | |||
---|---|---|---|---|---|---|
N = 59 Hospitals | N = 30 Hospitals | N = 29 Hospitals | ||||
Hospital Median (IQR) | Rate Pooled Across Hospitals | Hospital Median (IQR) | Rate Pooled Across Hospitals | Hospital Median (IQR) | Rate Pooled Across Hospitals | |
| ||||||
Baseline | 2.90 (0.00‐6.14) | 3.97 | 2.14 (0.00‐6.09) | 3.43 | 3.49 (0.00‐7.04) | 4.36 |
3 Month | 3.12 (0.00‐8.40) | 4.46 | 3.01 (0.00‐9.11) | 4.22 | 3.32 (0.00‐8.25) | 4.62 |
6 Month | 3.40 (0.00‐7.53) | 4.97 | 2.72 (0.00‐7.09) | 4.81 | 4.61 (0.00‐9.37) | 5.10 |
9 Month | 1.49 (0.00‐4.87) | 2.99 | 0 (0.00‐3.94) | 2.51 | 2.27 (0.00‐6.27) | 3.36 |
12 Month | 2.67 (0.00‐4.60) | 4.39 | 2.67 (0.00‐4.47) | 3.82 | 2.66 (0.00‐4.82) | 4.95 |
15 Month | 3.06 (0.00‐5.10) | 4.03 | 2.40 (0.00‐3.94) | 3.57 | 3.65 (1.15‐6.57) | 4.45 |
18 Month | 2.52 (0.00‐7.45) | 4.61 | 2.93 (0.00‐7.63) | 5.02 | 2.06 (0.00‐6.59) | 4.31 |
The poststudy survey was completed by 27 of 31 (87%) of Collaborative group hospitals and 19 of the 29 (66%) Toolkit hospitals. Both groups reported QI improvement efforts to prevent CLABSI (Collaborative 97% vs. Toolkit 88%, P = 0.29) and VAP (Collaborative 97% vs. Toolkit 96%, P = 0.99). Eighty‐three percent of the Collaborative group implemented all components of the bloodstream infection prevention interventions compared with 64% for the Toolkit group (P = 0.13; Figure 1). The Collaborative group implemented daily catheter review more often than the Toolkit group (P = 0.04) and began the process implementation sooner following study implementation (P = 0.006 vs. Toolkit; see Supporting Information Figure). Eighty‐six percent of the Collaborative group implemented the complete VAP prevention interventions vs. 64% of the Toolkit group (P = 0.06; Figure 1) and the Collaborative group conducted the sedation vacation intervention more often (P = 0.03).

The Collaborative group participated in 57% of the seminars, whereas the Toolkit group participated in 39% (P = 0.014). Members of both groups attended more than half the clinical topics (Collaborative 64% vs. Toolkit 56%, P = 0.37). The Collaborative group had greater participation in the data and method topics (Collaborative 50% vs. Toolkit 22%, P < 0.001). The proportion of hospitals finding the seminars useful to their QI efforts was 49% for the Collaborative and 30% for the Toolkit group (P = 0.017). When restricted to hospitals that participated in the seminars, the usefulness rating was higher for both clinical (91% for the Collaborative and 86% for Toolkit) and Data/Methods (79% for Collaborative and 55% for Toolkit) topics.
A set of 14 tools were produced during the study period (Table 4); 9 clinically related tools (eg, checklists, algorithms, protocols, and flowsheets) and 5 data monitoring and quality improvement tools (eg, easy‐to‐use statistical process control spreadsheet templates, quality improvement tools, and computer tools). The Collaborative group downloaded a median of 10 tools and the Toolkit group a median of 7 (P = 0.051). The groups did not differ in their access to the clinical tools (P = 0.23) but the Collaborative group accessed a greater proportion of the data/methods tools (P = 0.004).
Tool Access and Strategies | Collaborative Hospitalsa | Tool Kit Hospitalsa | P‐value |
---|---|---|---|
N = 36 ICUs | N = 25 ICUs | ||
| |||
Clinical Tool Use | 61% | 49% | 0.23 |
BSI Surveillance Guide | 22/36 (61%) | 13/25 (52%) | 0.60 |
BSI Checklist | 31/36 (86%) | 16/25 (64%) | 0.06 |
VAP Diagnosis Algorithm | 24/36 (67%) | 15/25 (60%) | 0.60 |
Ventilator Weaning Protocol | 23/36 (64%) | 11/25 (44%) | 0.18 |
VAP Surveillance Guide | 21/36 (58%) | 12/25 (48%) | 0.44 |
VAP Daily Assessment | 17/36 (47%) | 6/25 (24%) | 0.10 |
Ventilator Weaning Protocol (Flowsheet) | 15/36 (42%) | 11/25 (44%) | 0.99 |
Data Tools | 56% | 30% | 0.004 |
QI Implementation Tools | 19/36 (53%) | 6/25 (24%) | 0.03 |
BSI Statistical Process Control | 23/36 (64%) | 5/25 (20%) | 0.001 |
VAP Bundle | 23/36 (64%) | 11/25 (44%) | 0.18 |
VAP Statistical Process Control | 21/36 (58%) | 3/25 (12%) | 0.001 |
Strategies | 69% | 54% | 0.017 |
Protocols for BSI | 24/36 (67%) | 19/25 (76%) | 0.57 |
Protocols for VAP | 22/36 (61%) | 9/25 (36%) | 0.07 |
Computer Documentation for BSI | 24/36 (67%) | 13/25 (52%) | 0.29 |
Computer Documentation for VAP | 25/36 (69%) | 15/25 (60%) | 0.58 |
Increased Staffing | 3/36 (8%) | 0/25 (0%) | 0.26 |
Written Education for BSI | 31/36 (86%) | 19/25 (76%) | 0.33 |
Written Education for VAP | 30/36 (83%) | 19/25 (76%) | 0.52 |
Continuing Education Classes for BSI | 28/36 (78%) | 16/25 (64%) | 0.26 |
Continuing Education Classes for VAP | 30/36 (83%) | 17/25 (68%) | 0.21 |
QI teams | 27/36 (75%) | 14/25 (56%) | 0.16 |
Provider Performance Feedback for BSI | 23/36 (64%) | 11/25 (44%) | 0.18 |
Provider Performance Feedback for VAP | 24/36 (67%) | 11/25 (44%) | 0.11 |
Implementation of BSI Checklist | 28/36 (78%) | 15/25 (60%) | 0.16 |
Implementation of VAP Checklist | 31/36 (86%) | 13/25 (52%) | 0.007 |
Both groups relied primarily on implementation of protocols and informatics approaches (Table 4) without increasing staff levels. The predominant strategy was education; both groups provided written educational materials and classes to their providers. There was a trend for more Collaborative group members to implement QI teams (Table 4, P = 0.16 compared with the Toolkit group). Although the preponderance of both groups provided feedback reports to their hospital leaders and unit managers, Collaborative group hospitals showed a trend for providing feedback to front‐line providers (P = 0.11). With respect to self‐reported interventions, 78% of the Collaborative ICUs reported implementing a CLABSI checklist and 86% a VAP checklist, whereas only 60% of the Toolkit group reported implementation of a CLABSI checklist (P = 0.16) and 52% a VAP checklist (P = 0.007). Once a tool was implemented, both groups reported a high rate of sustaining the implementation (ranging from 86% to 100%). There also seemed to be a pattern of sequencing the interventions. Initial efforts tend to focus on provider education and evidence‐based protocols. Later efforts include more formal formation of QI teams followed by implementation of checklists. The evidence for sequencing of interventions is qualitative; we lacked subgroup sample size to substantiate these results with statistical analysis.
Discussion
In our investigation of Virtual Collaborative and Toolkit strategies for spreading the implementation of safe practices for CLABSI and VAP, ICUs in the Collaborative group had more complete implementation of the processes for prevention of hospital‐associated infections. Although both groups accessed clinical resources consistent with surveillance and clinical education, the Virtual Collaborative group attended to data and implementation methods more likely to lead to systemic CQI and organizational changes. ICUs that engaged these resources believed them useful in implementing QI, and more than 85% of the practices were sustained once integrated into routine care. Although the Collaborative ICUs were about 50% more likely to implement improvement strategies, these differences in implementation and process of care did not translate into group differences or longitudinal changes in infection rates.
In contrast to the context of our investigation, most published QI studies on health careassociated infection prevention report high baseline rates followed by a significant decline in infection rates.1419 The baseline infection rates in our study hospitals were actually below the endpoint found in many prior studies, suggesting that any marginal effects from our intervention would be more difficult to detect. Our study was implemented during the IHI's 100,000 Lives Campaign,20 a trend that may have brought about these lower baseline rates and thus a tighter margin for improvement.
The median CLABSI baseline rate in the well‐publicized Michigan hospital study was 2.7 per 1000 catheter days.21, 22 Although our baseline rate was similar (2.27 per 1000 catheter days), their reported postintervention rate was near zero, inferring nearly total elimination of the risk for CLABSI within 3‐18 months of study implementation. Several other studies using a collaborative approach have similarly reported high‐performance near‐zero results in reducing VAP23, 24 and CLABSI2528 rates. The difference between the present and previously published near‐zero result outcomes raises questions about collaboration‐based studies. We noticed 2 phenomena. First, there was slow uptake of data‐driven QI, and second, there was a differential uptake between general knowledge (clinical evidence and education) and QI implementation knowledge.29, 30
Lack of infrastructure to support data‐driven QI remains a significant barrier throughout the health care system, and teams in collaboratives often must work intensively toward improving their information systems' capability for the purpose of data‐driven decision support.1, 15, 31, 32 Systematic, standardized collection of CLABSI and VAP outcomes was initially lacking in many of our study hospitals,10 and our project expended early effort to deploy a system‐wide standardized infection control database registry.
Both of our study groups gravitated toward educational training and evidence‐based protocol decision‐support strategies. A focus only on established surveillance and education‐based fixes (eg, asking clinicians to follow a protocol within their existing care processes) have produced 32% to 57% reductions in health careacquired infections.3335 These early gains, however, are unlikely to produce the sustained near‐zero results that some collaborative teams have reported.22, 25
The ability to achieve sustained high‐performance results depends on organizational context and requires time.31 A potential benefit of collaboratives might be the return on investment attained by organizational change in quality and safety climate and its influence across the whole organization.19, 31, 36 Participants requiring systems training in the CQI process may not gain these benefits until well into their collaborative.31 For example, accumulating evidence demonstrates that the use of checklists can reduce errors of omission. Although a checklist seems a simple intervention, its effective implementation into routine care processes actually requires time for system redesign that addresses changes in multidisciplinary roles and responsibilities, frontline clinician and mid‐level management buy‐in, new methods of data collection and feedback, unanticipated involvement of ancillary services (eg, medical records, housekeeping), as well as changes to organizational policies, expectations, and priorities that connect silos of care and integrate hierarchical operations. Wall et al.37 and Pronovost and colleagues19, 21, 22, 25 highlighted the strategic effectiveness of embedding a checklist as a behavioral and data collection tool into frontline care process, leading to a redefined role of nursing, as well as new data for further cycles of improvement that collectively reduced infection rates. In our study, the Virtual Collaborative group did not have greater use of CLABSI and VAP checklists until the QI teams had been formed months into the project, consistent with the hypothesis that beneficial translation of desired changes in process of care to observed improvements in patient outcomes may take longer than 18 months to achieve19, 25, 27, 38 as opposed to the remarkable 3 months reported in the Keystone ICU project.21
Our study has several limitations. Our intervention did not mandate fixed specific components of intervention or QI methods. Each medical center was free to tailor its use of tools and change ideas, producing site variation in implementation methods and investment in support of QI. Like other multicomponent, multidimensional intervention studies, we were not able to test the effectiveness of particular QI components or the thoroughness of surveillance for CLABSI and VAP related to efforts to standardize the approach, and we did not have the resources to monitor the intensity with which participants approached QI. Furthermore, our data were dependent on self‐reports and were not verified by independent assessment of the fidelity with which the interventions were implemented, a checklist was embedded into usual care, or practices were enforced by nurses. In addition, the virtual collaborative circumvents the face‐to‐face learning sessions that might play a role in collaborative social networking, peer pressure, and acculturation.31, 36
Despite these limitations, we found that the Virtual Collaborative performed just like a Breakthrough Collaborative with a gradual uptake of implementation science using QI methods, team management, and statistical process control tools. The Toolkit condition had an even slower uptake. From an organization's perspective, the bottom‐line decision is whether a greater and meaningful proportion of collaborative participants will be successful to justify the investment of effort compared to a toolkit‐only approach. Our findings suggest that organizations engaged in change but lacking expertise in implementation science can potentially benefit from the acculturation, experiential learning, and uptake of QI provided by a collaborative.
In summary, although our Virtual Collaborative intervention was more likely to produce changes in ICU processes of care, there were no improvements in patient outcomes over this 18‐month study. The current popularity of evidence‐based guidelines, care protocols, prevention awareness, and surveillance may have produced a background of secular trend, making it difficult to ascertain effects of our QI intervention. Nonetheless, important lessons can be gleaned from this randomized controlled trial. Our study supports the proposition that as long as organizations vary in their capacity for and commitment to the science of QI and systems engineering, we should anticipate variation, uncertainty, and mixed results from short‐term, rapid cycle initiatives.27, 28, 31, 32, 39, 40 The untested, longer‐term benefit produced by a collaborative may be its stimulation of enduring systems engineering that optimizes an environment for QI of health care processes focused on desired outcomes.
Acknowledgements
The authors thank the Agency for Healthcare Research and Quality collaborative investigators for their work in this study: Xu Lei Liu, MS, at Vanderbilt; Laurie Brewer, RN MBA, Jason Hickok, Steve Horner, Susan Littleton, Patsy McFadden, RN BSN MPA CIC, Steve Mok, PharmD, Jonathan Perlin, MD PhD, Joan Reischel, RN BSN CCRN, and Sheri G. Chernestky Tejedor, MD, and all the HCA medical centers that participated in this project.
- Assessing the impact of continuous quality improvement on clinical practice: What it will take to accelerate progress.Milbank Q.1998;76:593–624. , , .
- Continuous improvement as an ideal in health care.N Engl J Med.1989;320:53–56. .
- A framework for collaborative improvement: Lessons from the Institute for Healthcare Improvement's Breakthrough Series.Qual Manag Health Care.1998;6(4):1–13. .
- Quality improvement learning collaboratives.Qual Manag Health Care.2005;14:234–237. , , , , , .
- Using a virtual breakthrough series collaborative to improve access in primary care.Jt Comm J Qual Patient Saf.2006;32:573–584. , , , .
- Taking the national guideline for care of acute myocardial infarction to the bedside: Developing the guideline applied in practice (GAP) initiative in Southeast Michigan.Jt Comm J Qual Improv.2002;28:5–19. , , , et al.
- Priority Areas for National Action: Transforming Health Care Quality.Washington, DC:The National Academies Press;2003. , .
- Optimal multivariate matching before randomization.Biostatistics.2004;5:263–275. , , , .
- Institute for Healthcare Improvement. The 100,000 lives campaign. http://www.ihi.org/IHI/Programs/Campaign.htm;2005.
- Survey of infection control programs in a large, national healthcare system.Infect Control Hosp Epidemiol.2007;28:1401–1403. , , , et al.
- 290–02‐0017 to the Stanford University‐UCSF Evidence‐based Practices Center), 2004. www.ahrq.gov/clinic/tp/qgap1tp.htm. Accessed November 11,2010. , , , . Closing the quality gap: A critical analysis of quality improvement strategies, Volume 1‐Series overview and methodology. Technical Review 9 (Contract No
- Improving safety on the front lines: the role of clinical microsystems.Qual Saf Health Care.2002;11:45–50. , .
- SamplePower 2.0.Chicago, IL:SPSS Inc.;2001. , , .
- Eliminating nosocomial infections at Ascension Health.Jt Comm J Qual Patient Saf.2006;32:612–620. , , , .
- An intensive care unit quality improvement collaborative in nine department of Veterans Affairs hospitals: reducing ventilator‐associated pneumonia and catheter‐related bloodstream infection rates.Jt Comm J Qual Patient Saf.2008;34:639–645. , , , et al.
- Decreasing ventilator‐associated pneumonia in a trauma ICU.J Trauma.2006;61:122–130. , , , et al.
- Use of corporate six sigma performance‐improvement strategies to reduce incidence of catheter‐related bloodstream infections in a surgical ICU.J Am Coll Surg.2005;201:349–358. , , , , , .
- Decline in ICU adverse events, nosocomial infections and cost through a quality improvement initiative focusing on teamwork and culture change.Qual Saf Health Care.2006;15:235–239. , , , , .
- Using a bundle approach to improve ventilator care processes and reduce ventilator‐associated pneumonia.Jt Comm J Qual Patient Saf.2005;31:243–248. , , , , , .
- The 100000 lives campaign: Setting a goal and a deadline for improving health care quality.JAMA.2006;295:324–327. , , , .
- An intervention to decrease catheter‐related bloodstream infections in the ICU.N Engl J Med.2006;355:2725–2732. , , .
- Improving patient safety units in Michigan.J Crit Care.2008;23:207–221. , , , et al.
- Toward a zero VAP rate: Personal and team approaches in the ICU.Crit Care Nurs Q.2006;29:108–114. .
- Implementing a ventilator bundle in a community hospital.Jt Comm J Qual Patient Saf.2007;33:219–225. , , , et al.
- Eliminating catheter‐realted bloodstream infections in the intensive care unit.Crit Care Med.2004;32:2014–2020. , , , et al.
- Innovative bundle wipes out catheter‐related bloodstream infections.Nursing.2008;38:17–18. .
- The CLABs collaborative: a regionwide effort to improve the quality of care in hospitals.Jt Comm J Qual Patient Saf.2008;34:713–723. , , , , , .
- Evidence‐based practice to reduce central line infections.Jt Comm J Qual Patient Saf.2006;32:253–260. , , , et al.
- Learning and improving in quality improvement collaboratives: which collaborative features do participants value most?Health Serv Res.2009;44(2 Pt 1):359–378. .
- Inside the health disparities collaboratives: a detailed exploration of quality improvement at community health centers.Med Care.2008;46:489–496. , , , et al.
- Quality collaboratives: lessons from research.Qual Saf Health Care.2002;11:345–351. , , , et al.
- Assessing the implementation of the chronic care model in quality improvement collaboratives.Health Serv Res.2005;40:978–996. , , , et al.
- Prevention of ventilator‐associated pneumonia: Analysis of studies published since 2004.J Hosp Infect.2007;67:1–8. , .
- Effect of comparative data feedback on intensive care unit infection rates in a Veterans Administration Hospital network system.Am J Infect Control.2003;31:397–404. , , , .
- Reducing ventilator‐associated pneumonia rates through a staff education programme.J Hosp Infect.2004;57:223–227. , , , et al.
- Does quality improvement implementation affect hospital quality of care?Hosp Top.2007;85:3–12. , , , .
- Using real‐time process measurements to reduce catheter‐related bloodstream infections in the intensive care unit.Qual Saf Health Care.2005;14:295–302. , , , , , .
- Prevention of ventilator‐associated pneumonia in the Calgary health region: a Canadian success story!Healthcare Qual.2008;11(3 Spec No):129–136. , , , , , .
- Creating the evidence base for quality improvement collaboratives.Ann Intern Med.2004;140:897–901. .
- Evidence for the impact of quality improvement collaboratives: systematic review.Br Med J.2008;336:1491–1494. , , , , .
- Assessing the impact of continuous quality improvement on clinical practice: What it will take to accelerate progress.Milbank Q.1998;76:593–624. , , .
- Continuous improvement as an ideal in health care.N Engl J Med.1989;320:53–56. .
- A framework for collaborative improvement: Lessons from the Institute for Healthcare Improvement's Breakthrough Series.Qual Manag Health Care.1998;6(4):1–13. .
- Quality improvement learning collaboratives.Qual Manag Health Care.2005;14:234–237. , , , , , .
- Using a virtual breakthrough series collaborative to improve access in primary care.Jt Comm J Qual Patient Saf.2006;32:573–584. , , , .
- Taking the national guideline for care of acute myocardial infarction to the bedside: Developing the guideline applied in practice (GAP) initiative in Southeast Michigan.Jt Comm J Qual Improv.2002;28:5–19. , , , et al.
- Priority Areas for National Action: Transforming Health Care Quality.Washington, DC:The National Academies Press;2003. , .
- Optimal multivariate matching before randomization.Biostatistics.2004;5:263–275. , , , .
- Institute for Healthcare Improvement. The 100,000 lives campaign. http://www.ihi.org/IHI/Programs/Campaign.htm;2005.
- Survey of infection control programs in a large, national healthcare system.Infect Control Hosp Epidemiol.2007;28:1401–1403. , , , et al.
- 290–02‐0017 to the Stanford University‐UCSF Evidence‐based Practices Center), 2004. www.ahrq.gov/clinic/tp/qgap1tp.htm. Accessed November 11,2010. , , , . Closing the quality gap: A critical analysis of quality improvement strategies, Volume 1‐Series overview and methodology. Technical Review 9 (Contract No
- Improving safety on the front lines: the role of clinical microsystems.Qual Saf Health Care.2002;11:45–50. , .
- SamplePower 2.0.Chicago, IL:SPSS Inc.;2001. , , .
- Eliminating nosocomial infections at Ascension Health.Jt Comm J Qual Patient Saf.2006;32:612–620. , , , .
- An intensive care unit quality improvement collaborative in nine department of Veterans Affairs hospitals: reducing ventilator‐associated pneumonia and catheter‐related bloodstream infection rates.Jt Comm J Qual Patient Saf.2008;34:639–645. , , , et al.
- Decreasing ventilator‐associated pneumonia in a trauma ICU.J Trauma.2006;61:122–130. , , , et al.
- Use of corporate six sigma performance‐improvement strategies to reduce incidence of catheter‐related bloodstream infections in a surgical ICU.J Am Coll Surg.2005;201:349–358. , , , , , .
- Decline in ICU adverse events, nosocomial infections and cost through a quality improvement initiative focusing on teamwork and culture change.Qual Saf Health Care.2006;15:235–239. , , , , .
- Using a bundle approach to improve ventilator care processes and reduce ventilator‐associated pneumonia.Jt Comm J Qual Patient Saf.2005;31:243–248. , , , , , .
- The 100000 lives campaign: Setting a goal and a deadline for improving health care quality.JAMA.2006;295:324–327. , , , .
- An intervention to decrease catheter‐related bloodstream infections in the ICU.N Engl J Med.2006;355:2725–2732. , , .
- Improving patient safety units in Michigan.J Crit Care.2008;23:207–221. , , , et al.
- Toward a zero VAP rate: Personal and team approaches in the ICU.Crit Care Nurs Q.2006;29:108–114. .
- Implementing a ventilator bundle in a community hospital.Jt Comm J Qual Patient Saf.2007;33:219–225. , , , et al.
- Eliminating catheter‐realted bloodstream infections in the intensive care unit.Crit Care Med.2004;32:2014–2020. , , , et al.
- Innovative bundle wipes out catheter‐related bloodstream infections.Nursing.2008;38:17–18. .
- The CLABs collaborative: a regionwide effort to improve the quality of care in hospitals.Jt Comm J Qual Patient Saf.2008;34:713–723. , , , , , .
- Evidence‐based practice to reduce central line infections.Jt Comm J Qual Patient Saf.2006;32:253–260. , , , et al.
- Learning and improving in quality improvement collaboratives: which collaborative features do participants value most?Health Serv Res.2009;44(2 Pt 1):359–378. .
- Inside the health disparities collaboratives: a detailed exploration of quality improvement at community health centers.Med Care.2008;46:489–496. , , , et al.
- Quality collaboratives: lessons from research.Qual Saf Health Care.2002;11:345–351. , , , et al.
- Assessing the implementation of the chronic care model in quality improvement collaboratives.Health Serv Res.2005;40:978–996. , , , et al.
- Prevention of ventilator‐associated pneumonia: Analysis of studies published since 2004.J Hosp Infect.2007;67:1–8. , .
- Effect of comparative data feedback on intensive care unit infection rates in a Veterans Administration Hospital network system.Am J Infect Control.2003;31:397–404. , , , .
- Reducing ventilator‐associated pneumonia rates through a staff education programme.J Hosp Infect.2004;57:223–227. , , , et al.
- Does quality improvement implementation affect hospital quality of care?Hosp Top.2007;85:3–12. , , , .
- Using real‐time process measurements to reduce catheter‐related bloodstream infections in the intensive care unit.Qual Saf Health Care.2005;14:295–302. , , , , , .
- Prevention of ventilator‐associated pneumonia in the Calgary health region: a Canadian success story!Healthcare Qual.2008;11(3 Spec No):129–136. , , , , , .
- Creating the evidence base for quality improvement collaboratives.Ann Intern Med.2004;140:897–901. .
- Evidence for the impact of quality improvement collaboratives: systematic review.Br Med J.2008;336:1491–1494. , , , , .
Copyright © 2011 Society of Hospital Medicine
Abuse Potential of Sleeping Agents: Liability Varies Among Agents
A supplement to Clinical Psychiatry News.
This CLINICAL UPDATE is supported by Takeda Pharmaceuticals North America, Inc.
•Introduction
•Topic Highlights
Click Here to view the supplement.
Introduction
Introduction
Roland R. Griffiths, PhD
Professor of Behavioral Biology
Departments of Psychiatry and Neuroscience
Johns Hopkins University
School of Medicine
Baltimore, Md.
Dr. Griffiths has disclosed that he is Principal Investigator of two grants from the National Institute on Drug Abuse (NIDA) (R01 DA03889 and R01 DA03890) and co-investigator on a contract and several other grants from NIDA. During the past 5 years, on issues about drug abuse liability, he has been a consultant to or received grants from the following pharmaceutical companies: Abbott Laboratories, Forest Laboratories Inc., Merck & Co., Inc., Neurocrine Biosciences, Inc., Novartis Pharmaceuticals Corporation, Orphan Medical, Pharmacia Corporation, Pfizer Inc., Takeda Pharmaceuticals, TransOral Pharmaceucticals, Inc., Somaxon Pharmaceuticals Inc., and Wyeth Pharmaceuticals. He has disclosed that he will be discussing non-medical use (ie, abuse) of various hypnotic drugs.
Topic Highlights
• Abuse Potential of Sleeping Agents: Liability Varies Among Agents
Insomnia: A Brief Review
Effects of Insomnia
Pharmacologic Treatment of Insomnia
Patterns of Sedative/Hypnotic Abuse
• Abuse Potential of Hypnotic Agents: Study Evaluates Relative Abuse Liability
Defining Relative Abuse Liability and Toxicity
Relative Abuse Liability Table
Results of Analysis
Copyright © 2006 Elsevier Inc.
A supplement to Clinical Psychiatry News.
This CLINICAL UPDATE is supported by Takeda Pharmaceuticals North America, Inc.
•Introduction
•Topic Highlights
Click Here to view the supplement.
Introduction
Introduction
Roland R. Griffiths, PhD
Professor of Behavioral Biology
Departments of Psychiatry and Neuroscience
Johns Hopkins University
School of Medicine
Baltimore, Md.
Dr. Griffiths has disclosed that he is Principal Investigator of two grants from the National Institute on Drug Abuse (NIDA) (R01 DA03889 and R01 DA03890) and co-investigator on a contract and several other grants from NIDA. During the past 5 years, on issues about drug abuse liability, he has been a consultant to or received grants from the following pharmaceutical companies: Abbott Laboratories, Forest Laboratories Inc., Merck & Co., Inc., Neurocrine Biosciences, Inc., Novartis Pharmaceuticals Corporation, Orphan Medical, Pharmacia Corporation, Pfizer Inc., Takeda Pharmaceuticals, TransOral Pharmaceucticals, Inc., Somaxon Pharmaceuticals Inc., and Wyeth Pharmaceuticals. He has disclosed that he will be discussing non-medical use (ie, abuse) of various hypnotic drugs.
Topic Highlights
• Abuse Potential of Sleeping Agents: Liability Varies Among Agents
Insomnia: A Brief Review
Effects of Insomnia
Pharmacologic Treatment of Insomnia
Patterns of Sedative/Hypnotic Abuse
• Abuse Potential of Hypnotic Agents: Study Evaluates Relative Abuse Liability
Defining Relative Abuse Liability and Toxicity
Relative Abuse Liability Table
Results of Analysis
Copyright © 2006 Elsevier Inc.
A supplement to Clinical Psychiatry News.
This CLINICAL UPDATE is supported by Takeda Pharmaceuticals North America, Inc.
•Introduction
•Topic Highlights
Click Here to view the supplement.
Introduction
Introduction
Roland R. Griffiths, PhD
Professor of Behavioral Biology
Departments of Psychiatry and Neuroscience
Johns Hopkins University
School of Medicine
Baltimore, Md.
Dr. Griffiths has disclosed that he is Principal Investigator of two grants from the National Institute on Drug Abuse (NIDA) (R01 DA03889 and R01 DA03890) and co-investigator on a contract and several other grants from NIDA. During the past 5 years, on issues about drug abuse liability, he has been a consultant to or received grants from the following pharmaceutical companies: Abbott Laboratories, Forest Laboratories Inc., Merck & Co., Inc., Neurocrine Biosciences, Inc., Novartis Pharmaceuticals Corporation, Orphan Medical, Pharmacia Corporation, Pfizer Inc., Takeda Pharmaceuticals, TransOral Pharmaceucticals, Inc., Somaxon Pharmaceuticals Inc., and Wyeth Pharmaceuticals. He has disclosed that he will be discussing non-medical use (ie, abuse) of various hypnotic drugs.
Topic Highlights
• Abuse Potential of Sleeping Agents: Liability Varies Among Agents
Insomnia: A Brief Review
Effects of Insomnia
Pharmacologic Treatment of Insomnia
Patterns of Sedative/Hypnotic Abuse
• Abuse Potential of Hypnotic Agents: Study Evaluates Relative Abuse Liability
Defining Relative Abuse Liability and Toxicity
Relative Abuse Liability Table
Results of Analysis
Copyright © 2006 Elsevier Inc.
Hospitalists Tackle Heart Failure
News that the cost of treating cardiovascular diseases is expected to triple by 2030 comes as a group of hospitalists already are tackling the issue head on.
Vikas Bhalla, MD, a hospitalist at Emory University Hospital in Atlanta, is one of a handful of hospitalists working with the Heart Failure Society of America (HFSA) in an attempt to develop a standardized care plan for HF patients. The approach would risk-stratify patients with the condition and potentially create support protocols to work with outpatient physicians.
Theoretically, Dr. Bhalla says, more outpatient support would ultimately benefit HM by reducing readmissions.
The discussions are "in the very early stages, but we deal with [HF patients] every day," he adds. "There are cardiologists that we invite for a consult on the patients, but there is no heart failure specialist. Nowadays, we have a super-specialty. … If there's a set of guidelines, maybe we can reduce the readmission grade."
The handling of HF patients, and those suffering from other cardiovascular diseases, is even more important in the wake of an American Heart Association (AHA) policy statement last month predicting that treatment costs for cardiovascular diseases would triple to $818 billion in 2030, up from $272 billion last year. The bulk of the costs are tied to hypertension and its "downstream diseases."
If cost-cutting isn't enough, Dr. Bhalla says, hospitalists should be even more motivated to combat HF as future funding rules are likely to not reimburse physicians for readmissions tied to the original case, the so-called bundling of payments. If HM can help solve the problem of readmissions, it can reduce overall costs and improve their own charge capture as well, he adds.
"This immense cost can be at least stopped from escalating, if not decreased, by having a standard of care across the board," Dr. Bhalla says.
News that the cost of treating cardiovascular diseases is expected to triple by 2030 comes as a group of hospitalists already are tackling the issue head on.
Vikas Bhalla, MD, a hospitalist at Emory University Hospital in Atlanta, is one of a handful of hospitalists working with the Heart Failure Society of America (HFSA) in an attempt to develop a standardized care plan for HF patients. The approach would risk-stratify patients with the condition and potentially create support protocols to work with outpatient physicians.
Theoretically, Dr. Bhalla says, more outpatient support would ultimately benefit HM by reducing readmissions.
The discussions are "in the very early stages, but we deal with [HF patients] every day," he adds. "There are cardiologists that we invite for a consult on the patients, but there is no heart failure specialist. Nowadays, we have a super-specialty. … If there's a set of guidelines, maybe we can reduce the readmission grade."
The handling of HF patients, and those suffering from other cardiovascular diseases, is even more important in the wake of an American Heart Association (AHA) policy statement last month predicting that treatment costs for cardiovascular diseases would triple to $818 billion in 2030, up from $272 billion last year. The bulk of the costs are tied to hypertension and its "downstream diseases."
If cost-cutting isn't enough, Dr. Bhalla says, hospitalists should be even more motivated to combat HF as future funding rules are likely to not reimburse physicians for readmissions tied to the original case, the so-called bundling of payments. If HM can help solve the problem of readmissions, it can reduce overall costs and improve their own charge capture as well, he adds.
"This immense cost can be at least stopped from escalating, if not decreased, by having a standard of care across the board," Dr. Bhalla says.
News that the cost of treating cardiovascular diseases is expected to triple by 2030 comes as a group of hospitalists already are tackling the issue head on.
Vikas Bhalla, MD, a hospitalist at Emory University Hospital in Atlanta, is one of a handful of hospitalists working with the Heart Failure Society of America (HFSA) in an attempt to develop a standardized care plan for HF patients. The approach would risk-stratify patients with the condition and potentially create support protocols to work with outpatient physicians.
Theoretically, Dr. Bhalla says, more outpatient support would ultimately benefit HM by reducing readmissions.
The discussions are "in the very early stages, but we deal with [HF patients] every day," he adds. "There are cardiologists that we invite for a consult on the patients, but there is no heart failure specialist. Nowadays, we have a super-specialty. … If there's a set of guidelines, maybe we can reduce the readmission grade."
The handling of HF patients, and those suffering from other cardiovascular diseases, is even more important in the wake of an American Heart Association (AHA) policy statement last month predicting that treatment costs for cardiovascular diseases would triple to $818 billion in 2030, up from $272 billion last year. The bulk of the costs are tied to hypertension and its "downstream diseases."
If cost-cutting isn't enough, Dr. Bhalla says, hospitalists should be even more motivated to combat HF as future funding rules are likely to not reimburse physicians for readmissions tied to the original case, the so-called bundling of payments. If HM can help solve the problem of readmissions, it can reduce overall costs and improve their own charge capture as well, he adds.
"This immense cost can be at least stopped from escalating, if not decreased, by having a standard of care across the board," Dr. Bhalla says.
Hospitalist Laments Level of Palliative Care
Bradley Flansbaum, DO, MPH, SFHM, director of the hospitalist program at Lenox Hill Hospital in New York City, recently posted "A Hospitalist's Lament," on the SHM-sponsored The Hospitalist Leader blog about the nuances of palliative care and advanced-care-planning discussions for patients nearing the end of life.
Dr. Flansbaum writes that, when asked to name a medical specialty other than HM that he might have enjoyed pursuing, he replies: "pain and palliative care." As he explains, "I didn’t discover that this was an area of interest for me until my career was much advanced," too late to pursue new opportunities for advanced training in palliative-care fellowships.
Yet he views eliciting the needs and wishes of terminally ill hospitalized patients as an art worth mastering. Hospitalists inevitably deal with end-of-life issues as a routine part of their jobs. "It's in our bailiwick. It's what we do, and it behooves us to get better at it," he says.
In his post, Dr. Flansbaum examines the recent medical literature (Sudore RL, Fried TR. Ann Int Med 2010;153:256; Perkins HS. Ann Int Med 2007;147:51-57; Sulmasy DP, Snyder L. JAMA 2010;304:1946-1947) questioning the benefits of advanced-care planning and advance-directive documents, such as living wills, in shaping the care patients want and need at the end of their lives. While these documents are not wasted effort, he says, "too often they're not very useful. We're learning that it's an incredibly dynamic process, contingent on cultural factors, and changing over time. One piece of paper with a static declaration isn't going to cover the bases. I've come to realize that it is about a talking, ongoing process."
Part of his "lament" as a hospitalist is that caring for terminally ill patients can be rife with ambiguities. Meanwhile, "everybody talks about how there's so much money wasted at the end of life, and we should be corralling our healthcare resources in a more efficient way. And yet the solutions we will need to get us to that place are damned hard," he says. (Listen to excerpts from the interview with Dr. Flansbaum [MP3 12.8MB])
Dr. Flansbaum recommends hospitalists make detailed conversations with patients confronting life-limiting illnesses a priority, which requires setting aside enough time for patients and understanding that such conversations are not singular events. He also encourages physicians to consider what their own values and priorities might be in such a situation, an exercise he recently conducted with his residents.
Bradley Flansbaum, DO, MPH, SFHM, director of the hospitalist program at Lenox Hill Hospital in New York City, recently posted "A Hospitalist's Lament," on the SHM-sponsored The Hospitalist Leader blog about the nuances of palliative care and advanced-care-planning discussions for patients nearing the end of life.
Dr. Flansbaum writes that, when asked to name a medical specialty other than HM that he might have enjoyed pursuing, he replies: "pain and palliative care." As he explains, "I didn’t discover that this was an area of interest for me until my career was much advanced," too late to pursue new opportunities for advanced training in palliative-care fellowships.
Yet he views eliciting the needs and wishes of terminally ill hospitalized patients as an art worth mastering. Hospitalists inevitably deal with end-of-life issues as a routine part of their jobs. "It's in our bailiwick. It's what we do, and it behooves us to get better at it," he says.
In his post, Dr. Flansbaum examines the recent medical literature (Sudore RL, Fried TR. Ann Int Med 2010;153:256; Perkins HS. Ann Int Med 2007;147:51-57; Sulmasy DP, Snyder L. JAMA 2010;304:1946-1947) questioning the benefits of advanced-care planning and advance-directive documents, such as living wills, in shaping the care patients want and need at the end of their lives. While these documents are not wasted effort, he says, "too often they're not very useful. We're learning that it's an incredibly dynamic process, contingent on cultural factors, and changing over time. One piece of paper with a static declaration isn't going to cover the bases. I've come to realize that it is about a talking, ongoing process."
Part of his "lament" as a hospitalist is that caring for terminally ill patients can be rife with ambiguities. Meanwhile, "everybody talks about how there's so much money wasted at the end of life, and we should be corralling our healthcare resources in a more efficient way. And yet the solutions we will need to get us to that place are damned hard," he says. (Listen to excerpts from the interview with Dr. Flansbaum [MP3 12.8MB])
Dr. Flansbaum recommends hospitalists make detailed conversations with patients confronting life-limiting illnesses a priority, which requires setting aside enough time for patients and understanding that such conversations are not singular events. He also encourages physicians to consider what their own values and priorities might be in such a situation, an exercise he recently conducted with his residents.
Bradley Flansbaum, DO, MPH, SFHM, director of the hospitalist program at Lenox Hill Hospital in New York City, recently posted "A Hospitalist's Lament," on the SHM-sponsored The Hospitalist Leader blog about the nuances of palliative care and advanced-care-planning discussions for patients nearing the end of life.
Dr. Flansbaum writes that, when asked to name a medical specialty other than HM that he might have enjoyed pursuing, he replies: "pain and palliative care." As he explains, "I didn’t discover that this was an area of interest for me until my career was much advanced," too late to pursue new opportunities for advanced training in palliative-care fellowships.
Yet he views eliciting the needs and wishes of terminally ill hospitalized patients as an art worth mastering. Hospitalists inevitably deal with end-of-life issues as a routine part of their jobs. "It's in our bailiwick. It's what we do, and it behooves us to get better at it," he says.
In his post, Dr. Flansbaum examines the recent medical literature (Sudore RL, Fried TR. Ann Int Med 2010;153:256; Perkins HS. Ann Int Med 2007;147:51-57; Sulmasy DP, Snyder L. JAMA 2010;304:1946-1947) questioning the benefits of advanced-care planning and advance-directive documents, such as living wills, in shaping the care patients want and need at the end of their lives. While these documents are not wasted effort, he says, "too often they're not very useful. We're learning that it's an incredibly dynamic process, contingent on cultural factors, and changing over time. One piece of paper with a static declaration isn't going to cover the bases. I've come to realize that it is about a talking, ongoing process."
Part of his "lament" as a hospitalist is that caring for terminally ill patients can be rife with ambiguities. Meanwhile, "everybody talks about how there's so much money wasted at the end of life, and we should be corralling our healthcare resources in a more efficient way. And yet the solutions we will need to get us to that place are damned hard," he says. (Listen to excerpts from the interview with Dr. Flansbaum [MP3 12.8MB])
Dr. Flansbaum recommends hospitalists make detailed conversations with patients confronting life-limiting illnesses a priority, which requires setting aside enough time for patients and understanding that such conversations are not singular events. He also encourages physicians to consider what their own values and priorities might be in such a situation, an exercise he recently conducted with his residents.
CLINICAL UPDATE: Selected Issues in Psychiatry
This CLINICAL UPDATE is supported by an educational grant from UCB Pharma, Inc., and is a supplement to Clinical Psychiatry News.
This supplement is based on a faculty interview and poster reviews.
Click Here To view the supplement.
Faculty
Joseph F. Goldberg, MD
Director of Bipolar Disorders Research
The Zucker Hillside Hospital-North Shore Long Island Jewish Health System
Glen Oaks, N.Y.
Received Funding for Clinical Grants/Consultant: Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company, and GlaxoSmithKline. He discusses the off-label use of levetiracetam for the treatment of psychiatric disorders.
Topics
• Anticonvulsants and Psychiatric Disorders
• Treatment of Varied Psychiatric Disorders in an Outpatient Setting
• Prevalence of ADHD in Adults
• Treatment of Mild or Moderate Bipolar Disorder
• Prevalence of Medical Comorbidity in Severe Psychiatric Disorders
• Evaluation of Therapy for Aggression Disorders
• Prevalence of Comorbid Anxiety Disorders
• Evaluation of Therapy for Bipolar Mania
• Evaluation of Add-On Therapy for Bipolar Disorder Therapy
Copyright © 2004 by International Medical News Group
This CLINICAL UPDATE is supported by an educational grant from UCB Pharma, Inc., and is a supplement to Clinical Psychiatry News.
This supplement is based on a faculty interview and poster reviews.
Click Here To view the supplement.
Faculty
Joseph F. Goldberg, MD
Director of Bipolar Disorders Research
The Zucker Hillside Hospital-North Shore Long Island Jewish Health System
Glen Oaks, N.Y.
Received Funding for Clinical Grants/Consultant: Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company, and GlaxoSmithKline. He discusses the off-label use of levetiracetam for the treatment of psychiatric disorders.
Topics
• Anticonvulsants and Psychiatric Disorders
• Treatment of Varied Psychiatric Disorders in an Outpatient Setting
• Prevalence of ADHD in Adults
• Treatment of Mild or Moderate Bipolar Disorder
• Prevalence of Medical Comorbidity in Severe Psychiatric Disorders
• Evaluation of Therapy for Aggression Disorders
• Prevalence of Comorbid Anxiety Disorders
• Evaluation of Therapy for Bipolar Mania
• Evaluation of Add-On Therapy for Bipolar Disorder Therapy
Copyright © 2004 by International Medical News Group
This CLINICAL UPDATE is supported by an educational grant from UCB Pharma, Inc., and is a supplement to Clinical Psychiatry News.
This supplement is based on a faculty interview and poster reviews.
Click Here To view the supplement.
Faculty
Joseph F. Goldberg, MD
Director of Bipolar Disorders Research
The Zucker Hillside Hospital-North Shore Long Island Jewish Health System
Glen Oaks, N.Y.
Received Funding for Clinical Grants/Consultant: Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company, and GlaxoSmithKline. He discusses the off-label use of levetiracetam for the treatment of psychiatric disorders.
Topics
• Anticonvulsants and Psychiatric Disorders
• Treatment of Varied Psychiatric Disorders in an Outpatient Setting
• Prevalence of ADHD in Adults
• Treatment of Mild or Moderate Bipolar Disorder
• Prevalence of Medical Comorbidity in Severe Psychiatric Disorders
• Evaluation of Therapy for Aggression Disorders
• Prevalence of Comorbid Anxiety Disorders
• Evaluation of Therapy for Bipolar Mania
• Evaluation of Add-On Therapy for Bipolar Disorder Therapy
Copyright © 2004 by International Medical News Group
BEST PRACTICES IN: Psychosocial Impact of Rosacea
A supplement to Skin & Allergy News. This supplement was sponsored by Galderma Laboratories, L.P.
- NRS Digital Perception Survey
- Presentation And Diagnosis
- Treatment Strategies
Faculty/Faculty Disclosure
Debra B. Luftman, MD
Coauthor of The Beauty Prescription:
The Complete Formula for Looking and Feeling Beautiful Calabasas, California
Dr Luftman has received funding for clinical grants from and is a consultant for Galderma Laboratories, L.P.
Copyright (c) 2011 Elsevier Inc.
A supplement to Skin & Allergy News. This supplement was sponsored by Galderma Laboratories, L.P.
- NRS Digital Perception Survey
- Presentation And Diagnosis
- Treatment Strategies
Faculty/Faculty Disclosure
Debra B. Luftman, MD
Coauthor of The Beauty Prescription:
The Complete Formula for Looking and Feeling Beautiful Calabasas, California
Dr Luftman has received funding for clinical grants from and is a consultant for Galderma Laboratories, L.P.
Copyright (c) 2011 Elsevier Inc.
A supplement to Skin & Allergy News. This supplement was sponsored by Galderma Laboratories, L.P.
- NRS Digital Perception Survey
- Presentation And Diagnosis
- Treatment Strategies
Faculty/Faculty Disclosure
Debra B. Luftman, MD
Coauthor of The Beauty Prescription:
The Complete Formula for Looking and Feeling Beautiful Calabasas, California
Dr Luftman has received funding for clinical grants from and is a consultant for Galderma Laboratories, L.P.
Copyright (c) 2011 Elsevier Inc.
A Rush for Technology Dollars? Not So Fast
HM program directors, particularly those involved in technology upgrades at their institutions, probably have heard a lot about electronic health record (EHR) attestation since the Centers for Medicare & Medicaid Services (CMS) announced that registration was open last month. But while CMS is pushing for physicians and hospitals to register as soon as possible, at least one informatics professional suggests that there is no major hurry to apply for the $20 billion the federal government has set aside for doctors and hospitals that adopt new technologies.
“I’m of the approach there is no rush to sign up even though we know we’re going for the funds,” says Anne M. Bobb, an informatics pharmacist in the Department of Quality and Clinical Informatics at Northwestern Memorial Hospital in Chicago. “We want to do it in a reasonable amount of time.”
Bobb, who works closely with the hospitalists at Northwestern Memorial, says that both “eligible professionals” and “eligible hospitals” have ample time to apply. She says applicants remain eligible for reimbursement as long as they register by fiscal year 2013 (eligible physicians [EP] and eligible hospitals [EH] need only 90 days of reporting for year one; measurements must begin and registration must be completed by EPs on July 3, 2013, and Oct. 3, 2013 for EHs). In addition, groups that register before then and stutter-step in their compliance because their nascent programs are just developing their protocol could jeopardize potential funding.
Those physicians and institutions that want certification must meet “meaningful use” criteria, defined by CMS last summer as meeting prescribed rules for implementation of EHR. Stage 1 rules, which take effect this year, require eligible physicians (EPs) and eligible hospitals to meet goals in 15 and 14 categories, respectively. Up to five goals can be deferred, according to CMS. The CMS timeline includes second and third stages, each of which will require goals that are even more advanced. The thresholds must be met to qualify for funding.
It’s understandable CMS wants to jump-start registration, but individual physicians and hospitals should take their time to determine what works best for them. “If you know you’re not going to make it for fiscal year 2011,” she asks rhetorically, “why go after it now?”
The registration process began Jan. 3 in Alaska, Iowa, Kentucky, Louisiana, Michigan, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, and Texas. More states, including California, are expected to open the process as early as this month.
For more information on what is needed to register, visit the EHR Incentive Program microsite. The EHR Information Center can be reached at 888-734-6433.
HM program directors, particularly those involved in technology upgrades at their institutions, probably have heard a lot about electronic health record (EHR) attestation since the Centers for Medicare & Medicaid Services (CMS) announced that registration was open last month. But while CMS is pushing for physicians and hospitals to register as soon as possible, at least one informatics professional suggests that there is no major hurry to apply for the $20 billion the federal government has set aside for doctors and hospitals that adopt new technologies.
“I’m of the approach there is no rush to sign up even though we know we’re going for the funds,” says Anne M. Bobb, an informatics pharmacist in the Department of Quality and Clinical Informatics at Northwestern Memorial Hospital in Chicago. “We want to do it in a reasonable amount of time.”
Bobb, who works closely with the hospitalists at Northwestern Memorial, says that both “eligible professionals” and “eligible hospitals” have ample time to apply. She says applicants remain eligible for reimbursement as long as they register by fiscal year 2013 (eligible physicians [EP] and eligible hospitals [EH] need only 90 days of reporting for year one; measurements must begin and registration must be completed by EPs on July 3, 2013, and Oct. 3, 2013 for EHs). In addition, groups that register before then and stutter-step in their compliance because their nascent programs are just developing their protocol could jeopardize potential funding.
Those physicians and institutions that want certification must meet “meaningful use” criteria, defined by CMS last summer as meeting prescribed rules for implementation of EHR. Stage 1 rules, which take effect this year, require eligible physicians (EPs) and eligible hospitals to meet goals in 15 and 14 categories, respectively. Up to five goals can be deferred, according to CMS. The CMS timeline includes second and third stages, each of which will require goals that are even more advanced. The thresholds must be met to qualify for funding.
It’s understandable CMS wants to jump-start registration, but individual physicians and hospitals should take their time to determine what works best for them. “If you know you’re not going to make it for fiscal year 2011,” she asks rhetorically, “why go after it now?”
The registration process began Jan. 3 in Alaska, Iowa, Kentucky, Louisiana, Michigan, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, and Texas. More states, including California, are expected to open the process as early as this month.
For more information on what is needed to register, visit the EHR Incentive Program microsite. The EHR Information Center can be reached at 888-734-6433.
HM program directors, particularly those involved in technology upgrades at their institutions, probably have heard a lot about electronic health record (EHR) attestation since the Centers for Medicare & Medicaid Services (CMS) announced that registration was open last month. But while CMS is pushing for physicians and hospitals to register as soon as possible, at least one informatics professional suggests that there is no major hurry to apply for the $20 billion the federal government has set aside for doctors and hospitals that adopt new technologies.
“I’m of the approach there is no rush to sign up even though we know we’re going for the funds,” says Anne M. Bobb, an informatics pharmacist in the Department of Quality and Clinical Informatics at Northwestern Memorial Hospital in Chicago. “We want to do it in a reasonable amount of time.”
Bobb, who works closely with the hospitalists at Northwestern Memorial, says that both “eligible professionals” and “eligible hospitals” have ample time to apply. She says applicants remain eligible for reimbursement as long as they register by fiscal year 2013 (eligible physicians [EP] and eligible hospitals [EH] need only 90 days of reporting for year one; measurements must begin and registration must be completed by EPs on July 3, 2013, and Oct. 3, 2013 for EHs). In addition, groups that register before then and stutter-step in their compliance because their nascent programs are just developing their protocol could jeopardize potential funding.
Those physicians and institutions that want certification must meet “meaningful use” criteria, defined by CMS last summer as meeting prescribed rules for implementation of EHR. Stage 1 rules, which take effect this year, require eligible physicians (EPs) and eligible hospitals to meet goals in 15 and 14 categories, respectively. Up to five goals can be deferred, according to CMS. The CMS timeline includes second and third stages, each of which will require goals that are even more advanced. The thresholds must be met to qualify for funding.
It’s understandable CMS wants to jump-start registration, but individual physicians and hospitals should take their time to determine what works best for them. “If you know you’re not going to make it for fiscal year 2011,” she asks rhetorically, “why go after it now?”
The registration process began Jan. 3 in Alaska, Iowa, Kentucky, Louisiana, Michigan, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, and Texas. More states, including California, are expected to open the process as early as this month.
For more information on what is needed to register, visit the EHR Incentive Program microsite. The EHR Information Center can be reached at 888-734-6433.
In the Literature: Research You Need to Know
Clinical question: Does early initiation of maintenance dialysis for patients with stage 5 chronic kidney disease affect survival?
Background: There is considerable variation in timing of dialysis for patients with chronic kidney disease, with a trend toward early initiation. Observational cohort and case control studies have suggested increased survival and quality of life and decreased complications with early initiation. More recent observational data, however, call this into question.
Study design: Randomized controlled trial.
Setting: Thirty-two centers in Australia and New Zealand.
Synopsis: A total of 828 patients were randomly assigned to the early-start group, in which patients would begin dialysis with an estimated glomerular filtration rate (GFR), using the Cockcroft-Gault Equation, of 10.0 ml to 14.0 ml per minute per 1.72 meters squared, or a late-start group in which dialysis would be initiated at a goal GFR of 5.0 ml/min to 7.0 ml/min.
Though 75.9% of patients in the late-start group initiated dialysis above the target rate due to symptoms or physician recommendation, the mean time to dialysis was still almost six months longer (7.40 months versus 1.80 months).
Patients were followed for a median of 3.59 years. Mortality was similar between the groups: 37.6% and 36.6% of the early-start group and late-start group died, respectively (hazard ratio 1.04, p=0.75). There was no significant difference in other adverse events (cardiovascular events, infections, or complications of dialysis) between the two groups.
The study could not be blinded but the adherence to a definitive endpoint of mortality limits the possibility of observation bias. Post hoc analysis with an alternative method of GFR assessment (the MDRD equation) yielded similar conclusions.
This is the first randomized controlled trial to look at this question, and while concordant with recent observational studies, the conclusions are inconsistent with existing guidelines from national and international groups. Adherence to guidelines recommending early initiation of dialysis is unlikely to improve clinical outcomes while significantly increasing costs.
Bottom line: Early initiation of dialysis is not associated with improved survival in patients with stage 5 chronic kidney disease compared with delaying dialysis to a goal GFR of 7.0 ml/min or the development of symptoms.
Citation: Cooper BA, Branley P, Bulfone L, et al. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med. 2010;363(7):609-619.
Reviewed for TH eWire by Jill Goldenberg, MD, Alan Briones, MD, Chad Craig, MD, Ramiro Jervis, MD, FHM, Brian Markoff, MD, FHM, Andrew Dunn, MD, FACP, FHM, Division of Hospital Medicine, Mount Sinai School of Medicine, New York City.
For more physician reviews of HM-related research, visit our website.
Clinical question: Does early initiation of maintenance dialysis for patients with stage 5 chronic kidney disease affect survival?
Background: There is considerable variation in timing of dialysis for patients with chronic kidney disease, with a trend toward early initiation. Observational cohort and case control studies have suggested increased survival and quality of life and decreased complications with early initiation. More recent observational data, however, call this into question.
Study design: Randomized controlled trial.
Setting: Thirty-two centers in Australia and New Zealand.
Synopsis: A total of 828 patients were randomly assigned to the early-start group, in which patients would begin dialysis with an estimated glomerular filtration rate (GFR), using the Cockcroft-Gault Equation, of 10.0 ml to 14.0 ml per minute per 1.72 meters squared, or a late-start group in which dialysis would be initiated at a goal GFR of 5.0 ml/min to 7.0 ml/min.
Though 75.9% of patients in the late-start group initiated dialysis above the target rate due to symptoms or physician recommendation, the mean time to dialysis was still almost six months longer (7.40 months versus 1.80 months).
Patients were followed for a median of 3.59 years. Mortality was similar between the groups: 37.6% and 36.6% of the early-start group and late-start group died, respectively (hazard ratio 1.04, p=0.75). There was no significant difference in other adverse events (cardiovascular events, infections, or complications of dialysis) between the two groups.
The study could not be blinded but the adherence to a definitive endpoint of mortality limits the possibility of observation bias. Post hoc analysis with an alternative method of GFR assessment (the MDRD equation) yielded similar conclusions.
This is the first randomized controlled trial to look at this question, and while concordant with recent observational studies, the conclusions are inconsistent with existing guidelines from national and international groups. Adherence to guidelines recommending early initiation of dialysis is unlikely to improve clinical outcomes while significantly increasing costs.
Bottom line: Early initiation of dialysis is not associated with improved survival in patients with stage 5 chronic kidney disease compared with delaying dialysis to a goal GFR of 7.0 ml/min or the development of symptoms.
Citation: Cooper BA, Branley P, Bulfone L, et al. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med. 2010;363(7):609-619.
Reviewed for TH eWire by Jill Goldenberg, MD, Alan Briones, MD, Chad Craig, MD, Ramiro Jervis, MD, FHM, Brian Markoff, MD, FHM, Andrew Dunn, MD, FACP, FHM, Division of Hospital Medicine, Mount Sinai School of Medicine, New York City.
For more physician reviews of HM-related research, visit our website.
Clinical question: Does early initiation of maintenance dialysis for patients with stage 5 chronic kidney disease affect survival?
Background: There is considerable variation in timing of dialysis for patients with chronic kidney disease, with a trend toward early initiation. Observational cohort and case control studies have suggested increased survival and quality of life and decreased complications with early initiation. More recent observational data, however, call this into question.
Study design: Randomized controlled trial.
Setting: Thirty-two centers in Australia and New Zealand.
Synopsis: A total of 828 patients were randomly assigned to the early-start group, in which patients would begin dialysis with an estimated glomerular filtration rate (GFR), using the Cockcroft-Gault Equation, of 10.0 ml to 14.0 ml per minute per 1.72 meters squared, or a late-start group in which dialysis would be initiated at a goal GFR of 5.0 ml/min to 7.0 ml/min.
Though 75.9% of patients in the late-start group initiated dialysis above the target rate due to symptoms or physician recommendation, the mean time to dialysis was still almost six months longer (7.40 months versus 1.80 months).
Patients were followed for a median of 3.59 years. Mortality was similar between the groups: 37.6% and 36.6% of the early-start group and late-start group died, respectively (hazard ratio 1.04, p=0.75). There was no significant difference in other adverse events (cardiovascular events, infections, or complications of dialysis) between the two groups.
The study could not be blinded but the adherence to a definitive endpoint of mortality limits the possibility of observation bias. Post hoc analysis with an alternative method of GFR assessment (the MDRD equation) yielded similar conclusions.
This is the first randomized controlled trial to look at this question, and while concordant with recent observational studies, the conclusions are inconsistent with existing guidelines from national and international groups. Adherence to guidelines recommending early initiation of dialysis is unlikely to improve clinical outcomes while significantly increasing costs.
Bottom line: Early initiation of dialysis is not associated with improved survival in patients with stage 5 chronic kidney disease compared with delaying dialysis to a goal GFR of 7.0 ml/min or the development of symptoms.
Citation: Cooper BA, Branley P, Bulfone L, et al. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med. 2010;363(7):609-619.
Reviewed for TH eWire by Jill Goldenberg, MD, Alan Briones, MD, Chad Craig, MD, Ramiro Jervis, MD, FHM, Brian Markoff, MD, FHM, Andrew Dunn, MD, FACP, FHM, Division of Hospital Medicine, Mount Sinai School of Medicine, New York City.
For more physician reviews of HM-related research, visit our website.
Hospitalists in Disaster Response
In the last decade, natural disasters such as the Indonesian tsunami of 2004, Hurricane Katrina in 2004, and the Pakistani earthquake of 2005 have brought attention to the importance of diverse but complementary medical professional roles in humanitarian medical aid.14 Natural disasters that cause significant physical trauma to large populations often necessitate initial multidisciplinary responder teams comprised of surgeons, anesthesiologists, emergency medicine physicians, surgical technologists, nurses, psychiatrists, and public health specialists. Their roles are to manage life‐threatening injuries, provide immediate triage, help affected individuals deal with intense psychological shock, and address critical population‐based needs such as water, food, and sanitation. Meanwhile, general medical, pediatric, rehabilitative, and long‐term psychiatric services often constitute a secondary tier of disaster response, providing postsurgical care, managing acute medical illnesses, mitigating psychological trauma, rehabilitating injuries, and providing vaccinations to at‐risk individuals. Hospitalists can play an important role in postcatastrophe recovery services as experts in acute care, stewards of care transitions, and drivers of systems improvement.
The earthquake that occurred January 12, 2010 in Haiti is a dramatic illustration of the importance of a multidisciplinary approach to disaster relief. The 7.0‐magnitude earthquake near Port‐au‐Prince ravaged an already crippled health care system, severely damaging the country's primary academic medical center, and killed the entire class of second‐year nursing students. The death toll has been estimated to be nearly one‐quarter of a million people.5 Victims awaiting surgery, recovering from surgery, or in need of other immediate medical attention quickly inundated any existing health facilities. The following stories describe the authors' respective experiences in Haiti after the earthquake.
JC: I arrived 4 days after the earthquake to a hospital outside of Port‐au‐Prince, spared from destruction, but filled with hundreds of patients with crush injuries and severe fractures. On rounds with the surgical team, I observed that venous thromboembolism (VTE) prophylaxis had not yet been initiated, and I was concerned that patients might die from pulmonary embolism. In the overwhelming urgency of providing life‐saving surgery to as many patients as possible, this simple measure had been overlooked. After discussion with our team and our Haitian medical colleagues, we initiated subcutaneous heparin on all eligible patients and made arrangements to receive further shipments of heparin to accommodate the influx of patients.
A nearby school and church had been annexed into makeshift extensions of the hospital wards. The volume and pace of incoming injuries was such that as soon as a patient was taken to surgery, another patient would often take his or her place in the bed. The rapid movement of patients to and from x‐ray, surgery, and postsurgical care created challenges around effective and accurate communication among multiple care providers. We decided that nonsurgical personnel would triage newly arriving patients and round on patients daily. Each nonsurgical physician was responsible for staffing a particular location. This zone‐defense approach ensured that the surgeons maximized their time in the operating rooms. We also instituted a basic system of portable medical records kept with each patient at all times, allowing personnel to easily and quickly assess care given to date, and to write notes and orders.
Presurgical and postsurgical wound infections became a common event, with the risk of ensuing sepsis. Antibiotic use was dependent on the preferences of individual surgeons and also on the available supply. As a result, antimicrobial treatments were highly variable and sometimes inadequate. The internists on the team proposed standard antibiotic guidelines for open fractures, for contaminated wounds, and for postoperative wounds; these regimens were approved and implemented by Haitian staff and the rest of the team.
Internists recognized the first complications of rhabdomyolysis from crush injuries and delays in receiving medical attention. Malaise, oliguria, and volume overload were often the only clues we had for severe renal failure. We had a functional lab capable of checking complete blood counts, urinalysis and creatinine, but we had a limited supply of serum potassium assays. We only used the latter in confirmed cases of rhabdomyolysis, and on several occasions we diagnosed severe hyperkalemia. Using bedside automated electrical defibrillation devices for monitoring, we sustained these patients on calcium gluconate until they could be transferred to an external dialysis unit run by Mdecins Sans Frontires in Port‐au‐Prince.6 As the number of rhabdomyolysis cases increased, we instigated creatinine rounds on patients arriving with large crush injuries, and we evaluated urine output daily until patients were clinically stable from this threat. We also helped the Haitian staff treat the omnipresent problem of pain and advised renal dosing of medications in renal failure and elderly patients.
GH: The situation 3 months after the earthquake was medically less dire but highlights the evolving importance of generalists in the aftermath of the quake.710 For many Haitian patients, the earthquake had become a universal point of reference for their symptomatology. Anorexia, amenorrhea, headaches, epigastric pain, even fungating soft tissue masses, were all reported to be depi tranbleman t a (since the earthquake) and were often somatic manifestations of a psychologically devastating event. At a hospital in Carrefour, I cared for patients presenting with dramatic sequelae of chronic diseases that had been undertreated due to the destruction of the Haitian medical infrastructurehypertensive coma, diabetic ketoacidosis, cerebral malaria, decompensated liver disease, and severe chronic anemia (including a patient with a hemoglobin of 3 mg/dL). I encountered many patients with infections exacerbated by excessive crowding in tent communities, such as typhoid and tuberculosis. At this particular hospital, priorities appropriately placed on surgical and postsurgical care required the team to devise creative solutions for the care and placement of medical patients, such as restructuring the emergency department and creating a rehabilitation tent on the hospital grounds. While few Haitian internists were present, a number of Haitian obstetricians were on site and helped manage medical conditions within the scope of their experience, such as hypertension, abdominal pain, and genitourinary infections. The expatriate orthopedic surgeons on site sought the consultative skills of hospitalists for preoperative management, postoperative complications, and comorbid conditions.
This hospital was largely sustained by rotating teams of volunteers, which underscored the importance of establishing a flexible system that would accommodate the turnover of personnel and fluctuating levels of professional expertise. The team used a tiered model for acute care delivery designating responsibilities based on the number of nurses, physicians, and other providers available. We collaborated with Haitian physicians to establish a routine of handoff rounds. Finally, we created and centralized documentation such as clinical protocols, contact numbers, and helpful tips for our successors.
Hospitalists have valuable skills to offer in medical responses to natural catastrophes.5 Our fluency with acute care environments becomes a pluripotent asset in disaster relief. Our experiences in assessing acuity are vital in assisting with inpatient triage. Our familiarity with the comanagement model facilitates partnership with other disciplines to optimize the distribution of skill sets without neglecting the overall well‐being of patients. Our clinical expertise in treating the vulnerable elderly, VTE, renal failure, pain management, postoperative infections, sepsis, and many other conditions can bolster medical relief efforts, even when the foremost need is surgical. The hospitalist's core competencies in healthcare systems11 can support recovery initiatives in medical facilities, particularly in the domains of drug safety, resource allocation, information management, team‐based methods, and care transitions. Our respective experiences also suggest the potential value of hospitalists in domestic, in addition to international, disaster response initiatives. Since large‐scale calamities may result in the hospitalization of overwhelming numbers of victims,12 hospitalists may be well‐positioned to assist our emergency medicine and public health colleagues, who currently (and fittingly) lead domestic efforts in disaster relief.
Tragedies like the earthquake in Haiti serve as a sobering reminder that a comprehensive multidisciplinary approach is required as medical disaster relief shifts from a life‐saving focus to one of life‐preserving care.13, 14 Hospitalists can play a vital role in these restorative efforts.
Acknowledgements
The authors thank their hospitalist colleagues at Beth Israel Deaconess who generously covered our shifts and encouraged us to write about our experiences.
- Health impact of the 2004 Andaman Nicobar earthquake and tsunami in Indonesia.Prehosp Disaster Med.2009;24(6):493–499. , .
- Medical response to hurricanes Katrina and Rita: local public health preparedness in action.J Public Health Manag Pract.2007;13(5):441–446. , , , .
- Nephrology in earthquakes: sharing experiences and information.Clin J Am Soc Nephrol.2007;2(4):803–808. .
- The Hospitalist. November2005. Hurricane Katrina: tragedy and hope. Available at: http://www.the‐hospitalist.org/details/article/255673/Hurricane_Katrina_Tragedy_and_Hope.html. Accessed August 2010.
- Washington Post. February 10,2010. Haiti raises earthquake toll to 230,000. Available at: http://www.washingtonpost.com/wp‐dyn/content/article/2010/02/09/AR2010020904447.html. Accessed August 2010.
- Médecins sans Frontiéres. About us. Available at: http://www.msf.org/msfinternational/aboutmsf/. Accessed August 2010.
- Practicing internal medicine onboard the USNS COMFORT in the aftermath of the Haitian earthquake.Ann Intern Med.2010;152(11):733–737. , , , et al.
- Minnesota Medicine. April2010. Help for Haiti. Available at: http://www.minnesotamedicine.com/PastIssues/April2010/CoverstoryApril2010/tabid/3370/Default.aspx. Accessed August 2010.
- The Hospitalist. April2010. Hospitalists in Haiti. Available at: http://www.the‐hospitalist.org/details/article/590287/Hospitalists_in_Haiti.html. Accessed August 2010.
- Haiti earthquake relief, phase two–long‐term needs and local resources.N Engl J Med.2010;362(20):1858–1861. .
- The core competencies in hospital medicine: a framework for curriculum development by the society of hospital medicine. J Hosp Med.2006;(1 Suppl 1):2–95. , , , , .
- The impact of the Tsunami on hospitalizations at the tertiary care hospital in the Southern Province of Sri Lanka.Am J Disaster Med.2008;3(3):147–155. , , , et al.
- Short communication: patterns of chronic and acute diseases after natural disasters ‐ a study from the International Committee of the Red Cross field hospital in Banda Aceh after the 2004 Indian Ocean tsunami.Trop Med Int Health.2007;12(11):1338–1341. , , .
- Characterisation of patients treated at the Red Cross field hospital in Kashmir during the first three weeks of operation.Emerg Med J.2006;23(8):654–656. , , .
In the last decade, natural disasters such as the Indonesian tsunami of 2004, Hurricane Katrina in 2004, and the Pakistani earthquake of 2005 have brought attention to the importance of diverse but complementary medical professional roles in humanitarian medical aid.14 Natural disasters that cause significant physical trauma to large populations often necessitate initial multidisciplinary responder teams comprised of surgeons, anesthesiologists, emergency medicine physicians, surgical technologists, nurses, psychiatrists, and public health specialists. Their roles are to manage life‐threatening injuries, provide immediate triage, help affected individuals deal with intense psychological shock, and address critical population‐based needs such as water, food, and sanitation. Meanwhile, general medical, pediatric, rehabilitative, and long‐term psychiatric services often constitute a secondary tier of disaster response, providing postsurgical care, managing acute medical illnesses, mitigating psychological trauma, rehabilitating injuries, and providing vaccinations to at‐risk individuals. Hospitalists can play an important role in postcatastrophe recovery services as experts in acute care, stewards of care transitions, and drivers of systems improvement.
The earthquake that occurred January 12, 2010 in Haiti is a dramatic illustration of the importance of a multidisciplinary approach to disaster relief. The 7.0‐magnitude earthquake near Port‐au‐Prince ravaged an already crippled health care system, severely damaging the country's primary academic medical center, and killed the entire class of second‐year nursing students. The death toll has been estimated to be nearly one‐quarter of a million people.5 Victims awaiting surgery, recovering from surgery, or in need of other immediate medical attention quickly inundated any existing health facilities. The following stories describe the authors' respective experiences in Haiti after the earthquake.
JC: I arrived 4 days after the earthquake to a hospital outside of Port‐au‐Prince, spared from destruction, but filled with hundreds of patients with crush injuries and severe fractures. On rounds with the surgical team, I observed that venous thromboembolism (VTE) prophylaxis had not yet been initiated, and I was concerned that patients might die from pulmonary embolism. In the overwhelming urgency of providing life‐saving surgery to as many patients as possible, this simple measure had been overlooked. After discussion with our team and our Haitian medical colleagues, we initiated subcutaneous heparin on all eligible patients and made arrangements to receive further shipments of heparin to accommodate the influx of patients.
A nearby school and church had been annexed into makeshift extensions of the hospital wards. The volume and pace of incoming injuries was such that as soon as a patient was taken to surgery, another patient would often take his or her place in the bed. The rapid movement of patients to and from x‐ray, surgery, and postsurgical care created challenges around effective and accurate communication among multiple care providers. We decided that nonsurgical personnel would triage newly arriving patients and round on patients daily. Each nonsurgical physician was responsible for staffing a particular location. This zone‐defense approach ensured that the surgeons maximized their time in the operating rooms. We also instituted a basic system of portable medical records kept with each patient at all times, allowing personnel to easily and quickly assess care given to date, and to write notes and orders.
Presurgical and postsurgical wound infections became a common event, with the risk of ensuing sepsis. Antibiotic use was dependent on the preferences of individual surgeons and also on the available supply. As a result, antimicrobial treatments were highly variable and sometimes inadequate. The internists on the team proposed standard antibiotic guidelines for open fractures, for contaminated wounds, and for postoperative wounds; these regimens were approved and implemented by Haitian staff and the rest of the team.
Internists recognized the first complications of rhabdomyolysis from crush injuries and delays in receiving medical attention. Malaise, oliguria, and volume overload were often the only clues we had for severe renal failure. We had a functional lab capable of checking complete blood counts, urinalysis and creatinine, but we had a limited supply of serum potassium assays. We only used the latter in confirmed cases of rhabdomyolysis, and on several occasions we diagnosed severe hyperkalemia. Using bedside automated electrical defibrillation devices for monitoring, we sustained these patients on calcium gluconate until they could be transferred to an external dialysis unit run by Mdecins Sans Frontires in Port‐au‐Prince.6 As the number of rhabdomyolysis cases increased, we instigated creatinine rounds on patients arriving with large crush injuries, and we evaluated urine output daily until patients were clinically stable from this threat. We also helped the Haitian staff treat the omnipresent problem of pain and advised renal dosing of medications in renal failure and elderly patients.
GH: The situation 3 months after the earthquake was medically less dire but highlights the evolving importance of generalists in the aftermath of the quake.710 For many Haitian patients, the earthquake had become a universal point of reference for their symptomatology. Anorexia, amenorrhea, headaches, epigastric pain, even fungating soft tissue masses, were all reported to be depi tranbleman t a (since the earthquake) and were often somatic manifestations of a psychologically devastating event. At a hospital in Carrefour, I cared for patients presenting with dramatic sequelae of chronic diseases that had been undertreated due to the destruction of the Haitian medical infrastructurehypertensive coma, diabetic ketoacidosis, cerebral malaria, decompensated liver disease, and severe chronic anemia (including a patient with a hemoglobin of 3 mg/dL). I encountered many patients with infections exacerbated by excessive crowding in tent communities, such as typhoid and tuberculosis. At this particular hospital, priorities appropriately placed on surgical and postsurgical care required the team to devise creative solutions for the care and placement of medical patients, such as restructuring the emergency department and creating a rehabilitation tent on the hospital grounds. While few Haitian internists were present, a number of Haitian obstetricians were on site and helped manage medical conditions within the scope of their experience, such as hypertension, abdominal pain, and genitourinary infections. The expatriate orthopedic surgeons on site sought the consultative skills of hospitalists for preoperative management, postoperative complications, and comorbid conditions.
This hospital was largely sustained by rotating teams of volunteers, which underscored the importance of establishing a flexible system that would accommodate the turnover of personnel and fluctuating levels of professional expertise. The team used a tiered model for acute care delivery designating responsibilities based on the number of nurses, physicians, and other providers available. We collaborated with Haitian physicians to establish a routine of handoff rounds. Finally, we created and centralized documentation such as clinical protocols, contact numbers, and helpful tips for our successors.
Hospitalists have valuable skills to offer in medical responses to natural catastrophes.5 Our fluency with acute care environments becomes a pluripotent asset in disaster relief. Our experiences in assessing acuity are vital in assisting with inpatient triage. Our familiarity with the comanagement model facilitates partnership with other disciplines to optimize the distribution of skill sets without neglecting the overall well‐being of patients. Our clinical expertise in treating the vulnerable elderly, VTE, renal failure, pain management, postoperative infections, sepsis, and many other conditions can bolster medical relief efforts, even when the foremost need is surgical. The hospitalist's core competencies in healthcare systems11 can support recovery initiatives in medical facilities, particularly in the domains of drug safety, resource allocation, information management, team‐based methods, and care transitions. Our respective experiences also suggest the potential value of hospitalists in domestic, in addition to international, disaster response initiatives. Since large‐scale calamities may result in the hospitalization of overwhelming numbers of victims,12 hospitalists may be well‐positioned to assist our emergency medicine and public health colleagues, who currently (and fittingly) lead domestic efforts in disaster relief.
Tragedies like the earthquake in Haiti serve as a sobering reminder that a comprehensive multidisciplinary approach is required as medical disaster relief shifts from a life‐saving focus to one of life‐preserving care.13, 14 Hospitalists can play a vital role in these restorative efforts.
Acknowledgements
The authors thank their hospitalist colleagues at Beth Israel Deaconess who generously covered our shifts and encouraged us to write about our experiences.
In the last decade, natural disasters such as the Indonesian tsunami of 2004, Hurricane Katrina in 2004, and the Pakistani earthquake of 2005 have brought attention to the importance of diverse but complementary medical professional roles in humanitarian medical aid.14 Natural disasters that cause significant physical trauma to large populations often necessitate initial multidisciplinary responder teams comprised of surgeons, anesthesiologists, emergency medicine physicians, surgical technologists, nurses, psychiatrists, and public health specialists. Their roles are to manage life‐threatening injuries, provide immediate triage, help affected individuals deal with intense psychological shock, and address critical population‐based needs such as water, food, and sanitation. Meanwhile, general medical, pediatric, rehabilitative, and long‐term psychiatric services often constitute a secondary tier of disaster response, providing postsurgical care, managing acute medical illnesses, mitigating psychological trauma, rehabilitating injuries, and providing vaccinations to at‐risk individuals. Hospitalists can play an important role in postcatastrophe recovery services as experts in acute care, stewards of care transitions, and drivers of systems improvement.
The earthquake that occurred January 12, 2010 in Haiti is a dramatic illustration of the importance of a multidisciplinary approach to disaster relief. The 7.0‐magnitude earthquake near Port‐au‐Prince ravaged an already crippled health care system, severely damaging the country's primary academic medical center, and killed the entire class of second‐year nursing students. The death toll has been estimated to be nearly one‐quarter of a million people.5 Victims awaiting surgery, recovering from surgery, or in need of other immediate medical attention quickly inundated any existing health facilities. The following stories describe the authors' respective experiences in Haiti after the earthquake.
JC: I arrived 4 days after the earthquake to a hospital outside of Port‐au‐Prince, spared from destruction, but filled with hundreds of patients with crush injuries and severe fractures. On rounds with the surgical team, I observed that venous thromboembolism (VTE) prophylaxis had not yet been initiated, and I was concerned that patients might die from pulmonary embolism. In the overwhelming urgency of providing life‐saving surgery to as many patients as possible, this simple measure had been overlooked. After discussion with our team and our Haitian medical colleagues, we initiated subcutaneous heparin on all eligible patients and made arrangements to receive further shipments of heparin to accommodate the influx of patients.
A nearby school and church had been annexed into makeshift extensions of the hospital wards. The volume and pace of incoming injuries was such that as soon as a patient was taken to surgery, another patient would often take his or her place in the bed. The rapid movement of patients to and from x‐ray, surgery, and postsurgical care created challenges around effective and accurate communication among multiple care providers. We decided that nonsurgical personnel would triage newly arriving patients and round on patients daily. Each nonsurgical physician was responsible for staffing a particular location. This zone‐defense approach ensured that the surgeons maximized their time in the operating rooms. We also instituted a basic system of portable medical records kept with each patient at all times, allowing personnel to easily and quickly assess care given to date, and to write notes and orders.
Presurgical and postsurgical wound infections became a common event, with the risk of ensuing sepsis. Antibiotic use was dependent on the preferences of individual surgeons and also on the available supply. As a result, antimicrobial treatments were highly variable and sometimes inadequate. The internists on the team proposed standard antibiotic guidelines for open fractures, for contaminated wounds, and for postoperative wounds; these regimens were approved and implemented by Haitian staff and the rest of the team.
Internists recognized the first complications of rhabdomyolysis from crush injuries and delays in receiving medical attention. Malaise, oliguria, and volume overload were often the only clues we had for severe renal failure. We had a functional lab capable of checking complete blood counts, urinalysis and creatinine, but we had a limited supply of serum potassium assays. We only used the latter in confirmed cases of rhabdomyolysis, and on several occasions we diagnosed severe hyperkalemia. Using bedside automated electrical defibrillation devices for monitoring, we sustained these patients on calcium gluconate until they could be transferred to an external dialysis unit run by Mdecins Sans Frontires in Port‐au‐Prince.6 As the number of rhabdomyolysis cases increased, we instigated creatinine rounds on patients arriving with large crush injuries, and we evaluated urine output daily until patients were clinically stable from this threat. We also helped the Haitian staff treat the omnipresent problem of pain and advised renal dosing of medications in renal failure and elderly patients.
GH: The situation 3 months after the earthquake was medically less dire but highlights the evolving importance of generalists in the aftermath of the quake.710 For many Haitian patients, the earthquake had become a universal point of reference for their symptomatology. Anorexia, amenorrhea, headaches, epigastric pain, even fungating soft tissue masses, were all reported to be depi tranbleman t a (since the earthquake) and were often somatic manifestations of a psychologically devastating event. At a hospital in Carrefour, I cared for patients presenting with dramatic sequelae of chronic diseases that had been undertreated due to the destruction of the Haitian medical infrastructurehypertensive coma, diabetic ketoacidosis, cerebral malaria, decompensated liver disease, and severe chronic anemia (including a patient with a hemoglobin of 3 mg/dL). I encountered many patients with infections exacerbated by excessive crowding in tent communities, such as typhoid and tuberculosis. At this particular hospital, priorities appropriately placed on surgical and postsurgical care required the team to devise creative solutions for the care and placement of medical patients, such as restructuring the emergency department and creating a rehabilitation tent on the hospital grounds. While few Haitian internists were present, a number of Haitian obstetricians were on site and helped manage medical conditions within the scope of their experience, such as hypertension, abdominal pain, and genitourinary infections. The expatriate orthopedic surgeons on site sought the consultative skills of hospitalists for preoperative management, postoperative complications, and comorbid conditions.
This hospital was largely sustained by rotating teams of volunteers, which underscored the importance of establishing a flexible system that would accommodate the turnover of personnel and fluctuating levels of professional expertise. The team used a tiered model for acute care delivery designating responsibilities based on the number of nurses, physicians, and other providers available. We collaborated with Haitian physicians to establish a routine of handoff rounds. Finally, we created and centralized documentation such as clinical protocols, contact numbers, and helpful tips for our successors.
Hospitalists have valuable skills to offer in medical responses to natural catastrophes.5 Our fluency with acute care environments becomes a pluripotent asset in disaster relief. Our experiences in assessing acuity are vital in assisting with inpatient triage. Our familiarity with the comanagement model facilitates partnership with other disciplines to optimize the distribution of skill sets without neglecting the overall well‐being of patients. Our clinical expertise in treating the vulnerable elderly, VTE, renal failure, pain management, postoperative infections, sepsis, and many other conditions can bolster medical relief efforts, even when the foremost need is surgical. The hospitalist's core competencies in healthcare systems11 can support recovery initiatives in medical facilities, particularly in the domains of drug safety, resource allocation, information management, team‐based methods, and care transitions. Our respective experiences also suggest the potential value of hospitalists in domestic, in addition to international, disaster response initiatives. Since large‐scale calamities may result in the hospitalization of overwhelming numbers of victims,12 hospitalists may be well‐positioned to assist our emergency medicine and public health colleagues, who currently (and fittingly) lead domestic efforts in disaster relief.
Tragedies like the earthquake in Haiti serve as a sobering reminder that a comprehensive multidisciplinary approach is required as medical disaster relief shifts from a life‐saving focus to one of life‐preserving care.13, 14 Hospitalists can play a vital role in these restorative efforts.
Acknowledgements
The authors thank their hospitalist colleagues at Beth Israel Deaconess who generously covered our shifts and encouraged us to write about our experiences.
- Health impact of the 2004 Andaman Nicobar earthquake and tsunami in Indonesia.Prehosp Disaster Med.2009;24(6):493–499. , .
- Medical response to hurricanes Katrina and Rita: local public health preparedness in action.J Public Health Manag Pract.2007;13(5):441–446. , , , .
- Nephrology in earthquakes: sharing experiences and information.Clin J Am Soc Nephrol.2007;2(4):803–808. .
- The Hospitalist. November2005. Hurricane Katrina: tragedy and hope. Available at: http://www.the‐hospitalist.org/details/article/255673/Hurricane_Katrina_Tragedy_and_Hope.html. Accessed August 2010.
- Washington Post. February 10,2010. Haiti raises earthquake toll to 230,000. Available at: http://www.washingtonpost.com/wp‐dyn/content/article/2010/02/09/AR2010020904447.html. Accessed August 2010.
- Médecins sans Frontiéres. About us. Available at: http://www.msf.org/msfinternational/aboutmsf/. Accessed August 2010.
- Practicing internal medicine onboard the USNS COMFORT in the aftermath of the Haitian earthquake.Ann Intern Med.2010;152(11):733–737. , , , et al.
- Minnesota Medicine. April2010. Help for Haiti. Available at: http://www.minnesotamedicine.com/PastIssues/April2010/CoverstoryApril2010/tabid/3370/Default.aspx. Accessed August 2010.
- The Hospitalist. April2010. Hospitalists in Haiti. Available at: http://www.the‐hospitalist.org/details/article/590287/Hospitalists_in_Haiti.html. Accessed August 2010.
- Haiti earthquake relief, phase two–long‐term needs and local resources.N Engl J Med.2010;362(20):1858–1861. .
- The core competencies in hospital medicine: a framework for curriculum development by the society of hospital medicine. J Hosp Med.2006;(1 Suppl 1):2–95. , , , , .
- The impact of the Tsunami on hospitalizations at the tertiary care hospital in the Southern Province of Sri Lanka.Am J Disaster Med.2008;3(3):147–155. , , , et al.
- Short communication: patterns of chronic and acute diseases after natural disasters ‐ a study from the International Committee of the Red Cross field hospital in Banda Aceh after the 2004 Indian Ocean tsunami.Trop Med Int Health.2007;12(11):1338–1341. , , .
- Characterisation of patients treated at the Red Cross field hospital in Kashmir during the first three weeks of operation.Emerg Med J.2006;23(8):654–656. , , .
- Health impact of the 2004 Andaman Nicobar earthquake and tsunami in Indonesia.Prehosp Disaster Med.2009;24(6):493–499. , .
- Medical response to hurricanes Katrina and Rita: local public health preparedness in action.J Public Health Manag Pract.2007;13(5):441–446. , , , .
- Nephrology in earthquakes: sharing experiences and information.Clin J Am Soc Nephrol.2007;2(4):803–808. .
- The Hospitalist. November2005. Hurricane Katrina: tragedy and hope. Available at: http://www.the‐hospitalist.org/details/article/255673/Hurricane_Katrina_Tragedy_and_Hope.html. Accessed August 2010.
- Washington Post. February 10,2010. Haiti raises earthquake toll to 230,000. Available at: http://www.washingtonpost.com/wp‐dyn/content/article/2010/02/09/AR2010020904447.html. Accessed August 2010.
- Médecins sans Frontiéres. About us. Available at: http://www.msf.org/msfinternational/aboutmsf/. Accessed August 2010.
- Practicing internal medicine onboard the USNS COMFORT in the aftermath of the Haitian earthquake.Ann Intern Med.2010;152(11):733–737. , , , et al.
- Minnesota Medicine. April2010. Help for Haiti. Available at: http://www.minnesotamedicine.com/PastIssues/April2010/CoverstoryApril2010/tabid/3370/Default.aspx. Accessed August 2010.
- The Hospitalist. April2010. Hospitalists in Haiti. Available at: http://www.the‐hospitalist.org/details/article/590287/Hospitalists_in_Haiti.html. Accessed August 2010.
- Haiti earthquake relief, phase two–long‐term needs and local resources.N Engl J Med.2010;362(20):1858–1861. .
- The core competencies in hospital medicine: a framework for curriculum development by the society of hospital medicine. J Hosp Med.2006;(1 Suppl 1):2–95. , , , , .
- The impact of the Tsunami on hospitalizations at the tertiary care hospital in the Southern Province of Sri Lanka.Am J Disaster Med.2008;3(3):147–155. , , , et al.
- Short communication: patterns of chronic and acute diseases after natural disasters ‐ a study from the International Committee of the Red Cross field hospital in Banda Aceh after the 2004 Indian Ocean tsunami.Trop Med Int Health.2007;12(11):1338–1341. , , .
- Characterisation of patients treated at the Red Cross field hospital in Kashmir during the first three weeks of operation.Emerg Med J.2006;23(8):654–656. , , .
Continuing Medical Education Program in
If you wish to receive credit for this activity, which begins on the next page, please refer to the website:
Accreditation and Designation Statement
Blackwell Futura Media Services designates this educational activity for a 1 AMA PRA Category 1 Credit. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Blackwell Futura Media Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Educational Objectives
Upon completion of this educational activity, participants will be better able to employ automated bed history data to examine outcomes of intra‐hospital transfers using all hospital admissions as the denominator.
Continuous participation in the Journal of Hospital Medicine CME program will enable learners to be better able to:
-
Interpret clinical guidelines and their applications for higher quality and more efficient care for all hospitalized patients.
-
Describe the standard of care for common illnesses and conditions treated in the hospital; such as pneumonia, COPD exacerbation, acute coronary syndrome, HF exacerbation, glycemic control, venous thromboembolic disease, stroke, etc.
-
Discuss evidence‐based recommendations involving transitions of care, including the hospital discharge process.
-
Gain insights into the roles of hospitalists as medical educators, researchers, medical ethicists, palliative care providers, and hospital‐based geriatricians.
-
Incorporate best practices for hospitalist administration, including quality improvement, patient safety, practice management, leadership, and demonstrating hospitalist value.
-
Identify evidence‐based best practices and trends for both adult and pediatric hospital medicine.
Instructions on Receiving Credit
For information on applicability and acceptance of continuing medical education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity during the valid credit period that is noted on the title page.
Follow these steps to earn credit:
-
Log on to
www.blackwellpublishing.com/cme . -
Read the target audience, learning objectives, and author disclosures.
-
Read the article in print or online format.
-
Reflect on the article.
-
Access the CME Exam, and choose the best answer to each question.
-
Complete the required evaluation component of the activity.
If you wish to receive credit for this activity, which begins on the next page, please refer to the website:
Accreditation and Designation Statement
Blackwell Futura Media Services designates this educational activity for a 1 AMA PRA Category 1 Credit. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Blackwell Futura Media Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Educational Objectives
Upon completion of this educational activity, participants will be better able to employ automated bed history data to examine outcomes of intra‐hospital transfers using all hospital admissions as the denominator.
Continuous participation in the Journal of Hospital Medicine CME program will enable learners to be better able to:
-
Interpret clinical guidelines and their applications for higher quality and more efficient care for all hospitalized patients.
-
Describe the standard of care for common illnesses and conditions treated in the hospital; such as pneumonia, COPD exacerbation, acute coronary syndrome, HF exacerbation, glycemic control, venous thromboembolic disease, stroke, etc.
-
Discuss evidence‐based recommendations involving transitions of care, including the hospital discharge process.
-
Gain insights into the roles of hospitalists as medical educators, researchers, medical ethicists, palliative care providers, and hospital‐based geriatricians.
-
Incorporate best practices for hospitalist administration, including quality improvement, patient safety, practice management, leadership, and demonstrating hospitalist value.
-
Identify evidence‐based best practices and trends for both adult and pediatric hospital medicine.
Instructions on Receiving Credit
For information on applicability and acceptance of continuing medical education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity during the valid credit period that is noted on the title page.
Follow these steps to earn credit:
-
Log on to
www.blackwellpublishing.com/cme . -
Read the target audience, learning objectives, and author disclosures.
-
Read the article in print or online format.
-
Reflect on the article.
-
Access the CME Exam, and choose the best answer to each question.
-
Complete the required evaluation component of the activity.
If you wish to receive credit for this activity, which begins on the next page, please refer to the website:
Accreditation and Designation Statement
Blackwell Futura Media Services designates this educational activity for a 1 AMA PRA Category 1 Credit. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Blackwell Futura Media Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Educational Objectives
Upon completion of this educational activity, participants will be better able to employ automated bed history data to examine outcomes of intra‐hospital transfers using all hospital admissions as the denominator.
Continuous participation in the Journal of Hospital Medicine CME program will enable learners to be better able to:
-
Interpret clinical guidelines and their applications for higher quality and more efficient care for all hospitalized patients.
-
Describe the standard of care for common illnesses and conditions treated in the hospital; such as pneumonia, COPD exacerbation, acute coronary syndrome, HF exacerbation, glycemic control, venous thromboembolic disease, stroke, etc.
-
Discuss evidence‐based recommendations involving transitions of care, including the hospital discharge process.
-
Gain insights into the roles of hospitalists as medical educators, researchers, medical ethicists, palliative care providers, and hospital‐based geriatricians.
-
Incorporate best practices for hospitalist administration, including quality improvement, patient safety, practice management, leadership, and demonstrating hospitalist value.
-
Identify evidence‐based best practices and trends for both adult and pediatric hospital medicine.
Instructions on Receiving Credit
For information on applicability and acceptance of continuing medical education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity during the valid credit period that is noted on the title page.
Follow these steps to earn credit:
-
Log on to
www.blackwellpublishing.com/cme . -
Read the target audience, learning objectives, and author disclosures.
-
Read the article in print or online format.
-
Reflect on the article.
-
Access the CME Exam, and choose the best answer to each question.
-
Complete the required evaluation component of the activity.